Cell	O
cycle	O
analysis	O
of	O
E2F	B-protein
in	O
primary	B-cell_type
human	I-cell_type
T	I-cell_type
cells	I-cell_type
reveals	O
novel	B-protein
E2F	I-protein
complexes	I-protein
and	O
biochemically	O
distinct	O
forms	O
of	O
free	O
E2F	B-protein
.	O

The	O
transcription	B-protein
factor	I-protein
E2F	B-protein
activates	O
the	O
expression	O
of	O
multiple	O
genes	B-DNA
involved	O
in	O
cell	O
proliferation	O
,	O
such	O
as	O
c-myc	B-DNA
and	O
the	O
dihydrofolate	B-DNA
reductase	I-DNA
gene	I-DNA
.	O

Regulation	O
of	O
E2F	B-protein
involves	O
its	O
interactions	O
with	O
other	O
cellular	B-protein
proteins	I-protein
,	O
including	O
the	O
retinoblastoma	B-protein
protein	I-protein
(	O
Rb	B-protein
)	O
,	O
the	O
Rb-related	B-protein
protein	I-protein
p107	B-protein
,	O
cyclin	B-protein
A	I-protein
,	O
and	O
cdk2	B-protein
.	O

We	O
undertook	O
a	O
detailed	O
analysis	O
of	O
E2F	B-protein
DNA-binding	O
activities	O
and	O
their	O
cell	O
cycle	O
behavior	O
in	O
primary	O
human	O
T	B-cell_type
cells	I-cell_type
.	O

Three	O
E2F	B-protein
DNA-binding	O
activities	O
were	O
identified	O
in	O
resting	O
(	O
G0	O
)	O
T	B-cell_type
cells	I-cell_type
with	O
mobilities	O
in	O
gel	O
shift	O
assays	O
distinct	O
from	O
those	O
of	O
previously	O
defined	O
E2F	B-protein
complexes	O
.	O

One	O
of	O
these	O
activities	O
was	O
found	O
to	O
be	O
a	O
novel	O
,	O
less	O
abundant	O
,	O
Rb-	O
E2F	B-protein
complex	O
.	O

The	O
most	O
prominent	O
E2F	B-protein
activity	O
in	O
resting	O
T	B-cell_type
cells	I-cell_type
(	O
termed	O
complex	O
X	O
)	O
was	O
abundant	O
in	O
both	O
G0	O
and	O
G1	O
but	O
disappeared	O
as	O
cells	O
entered	O
S	O
phase	O
,	O
suggesting	O
a	O
possible	O
role	O
in	O
negatively	O
regulating	O
E2F	B-protein
function	O
.	O

Complex	B-protein
X	I-protein
could	O
be	O
dissociated	O
by	O
adenovirus	O
E1A	O
with	O
a	O
requirement	O
for	O
an	O
intact	O
E1A	B-DNA
conserved	I-DNA
region	I-DNA
2	I-DNA
.	O

However	O
,	O
X	B-protein
failed	O
to	O
react	O
with	O
a	O
variety	O
of	O
antibodies	O
against	O
Rb	B-protein
or	O
p107	B-protein
,	O
implicating	O
the	O
involvement	O
of	O
an	O
E1A-binding	B-protein
protein	I-protein
other	O
than	O
Rb	B-protein
or	O
p107	B-protein
.	O

In	O
addition	O
to	O
these	O
novel	B-protein
E2F	I-protein
complexes	I-protein
,	O
three	O
distinct	O
forms	O
of	O
unbound	O
(	O
free	O
)	O
E2F	B-protein
were	O
resolved	O
in	O
gel	O
shift	O
experiments	O
.	O

These	O
species	O
showed	O
different	O
cell	O
cycle	O
kinetics	O
.	O

UV	O
cross-linking	O
experiments	O
suggested	O
that	O
a	O
distinct	O
E2F	B-protein
DNA-binding	O
protein	O
is	O
uniquely	O
associated	O
with	O
the	O
S-phase	B-protein
p107	I-protein
complex	I-protein
and	O
is	O
not	O
associated	O
with	O
Rb	B-protein
.	O

Together	O
,	O
these	O
results	O
suggest	O
that	O
E2F	B-protein
consists	O
of	O
multiple	O
,	O
biochemically	O
distinct	O
DNA-binding	B-protein
proteins	I-protein
which	O
function	O
at	O
different	O
points	O
in	O
the	O
cell	O
cycle	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
July	NULL
1993	NULL
,	NULL
p.	NULL
3975-3983	NULL
0270-7306/93/073975-09	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
Â©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

13	NULL
,	NULL
No	NULL
.	NULL

7	NULL
Cell	NULL
Cycle	NULL
Analysis	NULL
of	NULL
E2F	NULL
in	NULL
Primary	NULL
Human	NULL
T	NULL
Cells	NULL
Reveals	NULL
Novel	NULL
E2F	NULL
Complexes	NULL
and	NULL
Biochemically	NULL
Distinct	NULL
Forms	NULL
of	NULL
Free	NULL
E2F	NULL
THOMAS	NULL
CHITTENDEN	NULL
,	NULL
DAVID	NULL
M.	NULL
LIVINGSTON	NULL
,	NULL
*	NULL
anp	NULL
JAMES	NULL
A.	NULL
DeCAPRIO	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
and	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
44	NULL
Binney	NULL
Street	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
Received	NULL
6	NULL
January	NULL
1993/Returned	NULL
for	NULL
modification	NULL
9	NULL
February	NULL
1993/Accepted	NULL
16	NULL
April	NULL
1993	NULL
The	NULL
transcription	NULL
factor	NULL
E2F	NULL
activates	NULL
the	NULL
expression	NULL
of	NULL
multiple	NULL
genes	NULL
involved	NULL
in	NULL
cell	NULL
proliferation	NULL
,	NULL
such	NULL
as	NULL
c-myc	NULL
and	NULL
the	NULL
dihydrofolate	NULL
reductase	NULL
gene	NULL
.	NULL

Regulation	NULL
of	NULL
E2F	NULL
involves	NULL
its	NULL
interactions	NULL
with	NULL
other	NULL
cellular	NULL
proteins	NULL
,	NULL
including	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
(	NULL
Rb	NULL
)	NULL
,	NULL
the	NULL
Rb-related	NULL
protein	NULL
p107	NULL
,	NULL
cyclin	NULL
A	NULL
,	NULL
and	NULL
cdk2	NULL
.	NULL

We	NULL
undertook	NULL
a	NULL
detailed	NULL
analysis	NULL
of	NULL
E2F	NULL
DNA-binding	NULL
activities	NULL
and	NULL
their	NULL
cell	NULL
cycle	NULL
behavior	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

Three	NULL
E2F	NULL
DNA-binding	NULL
activities	NULL
were	NULL
identified	NULL
in	NULL
resting	NULL
(	NULL
G	NULL
,	NULL
)	NULL
T	NULL
cells	NULL
with	NULL
mobilities	NULL
in	NULL
gel	NULL
shift	NULL
assays	NULL
distinct	NULL
from	NULL
those	NULL
of	NULL
previously	NULL
defined	NULL
E2F	NULL
complexes	NULL
.	NULL

One	NULL
of	NULL
these	NULL
activities	NULL
was	NULL
found	NULL
to	NULL
be	NULL
a	NULL
novel	NULL
,	NULL
less	NULL
abundant	NULL
,	NULL
Rb-E2F	NULL
complex	NULL
.	NULL

The	NULL
most	NULL
prominent	NULL
E2F	NULL
activity	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
(	NULL
termed	NULL
complex	NULL
X	NULL
)	NULL
was	NULL
abundant	NULL
in	NULL
both	NULL
G	NULL
,	NULL
and	NULL
G	NULL
,	NULL
but	NULL
disappeared	NULL
as	NULL
cells	NULL
entered	NULL
S	NULL
phase	NULL
,	NULL
suggesting	NULL
a	NULL
possible	NULL
role	NULL
in	NULL
negatively	NULL
regulating	NULL
E2F	NULL
function	NULL
.	NULL

Complex	NULL
X	NULL
could	NULL
be	NULL
dissociated	NULL
by	NULL
adenovirus	NULL
E1A	NULL
with	NULL
a	NULL
requirement	NULL
for	NULL
an	NULL
intact	NULL
E1A	NULL
conserved	NULL
region	NULL
2	NULL
.	NULL

However	NULL
,	NULL
X	NULL
failed	NULL
to	NULL
react	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
antibodies	NULL
against	NULL
Rb	NULL
or	NULL
p107	NULL
,	NULL
implicating	NULL
the	NULL
involvement	NULL
of	NULL
an	NULL
E1A-binding	NULL
protein	NULL
other	NULL
than	NULL
Rb	NULL
or	NULL
p107	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
these	NULL
novel	NULL
E2F	NULL
complexes	NULL
,	NULL
three	NULL
distinct	NULL
forms	NULL
of	NULL
unbound	NULL
(	NULL
free	NULL
)	NULL
E2F	NULL
were	NULL
resolved	NULL
in	NULL
gel	NULL
shift	NULL
experiments	NULL
.	NULL

These	NULL
species	NULL
showed	NULL
different	NULL
cell	NULL
cycle	NULL
kinetics	NULL
.	NULL

UV	NULL
cross-linking	NULL
experiments	NULL
suggested	NULL
that	NULL
a	NULL
distinct	NULL
E2F	NULL
DNA-binding	NULL
protein	NULL
is	NULL
uniquely	NULL
associated	NULL
with	NULL
the	NULL
S-phase	NULL
p107	NULL
complex	NULL
and	NULL
is	NULL
not	NULL
associated	NULL
with	NULL
Rb	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
E2F	NULL
consists	NULL
of	NULL
multiple	NULL
,	NULL
biochemically	NULL
distinct	NULL
DNA-binding	NULL
proteins	NULL
which	NULL
function	NULL
at	NULL
different	NULL
points	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
E2F	NULL
was	NULL
originally	NULL
identified	NULL
as	NULL
an	NULL
element	NULL
needed	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
specific	NULL
adenoviral	NULL
early	NULL
promoter	NULL
(	NULL
pE2A	NULL
)	NULL
(	NULL
20	NULL
,	NULL
21	NULL
,	NULL
44	NULL
)	NULL
.	NULL

ELA	NULL
stimulation	NULL
of	NULL
the	NULL
viral	NULL
E2	NULL
transcription	NULL
unit	NULL
requires	NULL
the	NULL
interaction	NULL
of	NULL
E2F	NULL
with	NULL
the	NULL
sequence	NULL
TTTCGCG	NULL
,	NULL
represented	NULL
twice	NULL
within	NULL
the	NULL
E2	NULL
promoter	NULL
(	NULL
23	NULL
,	NULL
43	NULL
)	NULL
.	NULL

A	NULL
second	NULL
viral	NULL
protein	NULL
,	NULL
the	NULL
19-kDa	NULL
E4	NULL
protein	NULL
,	NULL
interacts	NULL
with	NULL
E2F	NULL
and	NULL
promotes	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
stable	NULL
DNA-binding	NULL
complex	NULL
on	NULL
the	NULL
E2	NULL
promoter	NULL
binding	NULL
sites	NULL
(	NULL
17	NULL
,	NULL
25	NULL
,	NULL
29	NULL
,	NULL
36	NULL
)	NULL
.	NULL

While	NULL
adenovirus	NULL
recruits	NULL
E2F	NULL
during	NULL
infection	NULL
to	NULL
activate	NULL
viral	NULL
promoters	NULL
,	NULL
one	NULL
normal	NULL
cellular	NULL
function	NULL
of	NULL
E2F	NULL
is	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
multiple	NULL
growth-responsive	NULL
cellular	NULL
genes	NULL
,	NULL
many	NULL
of	NULL
which	NULL
contribute	NULL
to	NULL
DNA	NULL
synthesis	NULL
.	NULL

E2F	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
the	NULL
c-myc	NULL
,	NULL
c-myb	NULL
,	NULL
N-myc	NULL
,	NULL
dihydrofolate	NULL
reductase	NULL
(	NULL
DHFR	NULL
)	NULL
,	NULL
thymidine	NULL
kinase	NULL
,	NULL
DNA	NULL
polymerase	NULL
a	NULL
,	NULL
and	NULL
cdc2	NULL
genes	NULL
(	NULL
4	NULL
,	NULL
9	NULL
,	NULL
14	NULL
,	NULL
16	NULL
,	NULL
28	NULL
,	NULL
30	NULL
,	NULL
33	NULL
,	NULL
39	NULL
)	NULL
.	NULL

The	NULL
E2F	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
P2	NULL
promoter	NULL
of	NULL
c-myc	NULL
is	NULL
required	NULL
for	NULL
activation	NULL
of	NULL
myc	NULL
following	NULL
serum	NULL
stimulation	NULL
(	NULL
28	NULL
)	NULL
;	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
DHFR	NULL
gene	NULL
,	NULL
the	NULL
E2F	NULL
site	NULL
is	NULL
important	NULL
for	NULL
increased	NULL
expression	NULL
at	NULL
the	NULL
G	NULL
,	NULL
/S	NULL
boundary	NULL
(	NULL
26	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
suggest	NULL
that	NULL
E2F	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
imparting	NULL
appropriate	NULL
cell	NULL
cycle	NULL
regulated	NULL
transcription	NULL
to	NULL
genes	NULL
that	NULL
govern	NULL
cell	NULL
growth	NULL
.	NULL

Regulation	NULL
of	NULL
E2F	NULL
involves	NULL
interactions	NULL
with	NULL
multiple	NULL
cellular	NULL
proteins	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
30	NULL
)	NULL
.	NULL

The	NULL
retinoblastoma	NULL
susceptibility	NULL
protein	NULL
(	NULL
Rb	NULL
)	NULL
,	NULL
which	NULL
has	NULL
served	NULL
as	NULL
a	NULL
paradigm	NULL
for	NULL
a	NULL
tumor	NULL
suppressor	NULL
,	NULL
forms	NULL
a	NULL
specific	NULL
complex	NULL
with	NULL
E2F	NULL
(	NULL
2	NULL
,	NULL
3	NULL
,	NULL
6	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Loss	NULL
of	NULL
Rb	NULL
function	NULL
,	NULL
by	NULL
deletion	NULL
or	NULL
mutation	NULL
,	NULL
occurs	NULL
in	NULL
all	NULL
retinoblastomas	NULL
and	NULL
is	NULL
a	NULL
frequent	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

3975	NULL
event	NULL
in	NULL
certain	NULL
other	NULL
human	NULL
tumors	NULL
as	NULL
well	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Rb-E2F	NULL
binding	NULL
may	NULL
be	NULL
an	NULL
important	NULL
component	NULL
of	NULL
the	NULL
mechanism	NULL
whereby	NULL
Rb	NULL
negatively	NULL
regulates	NULL
cell	NULL
growth	NULL
,	NULL
since	NULL
loss-of-function	NULL
mutant	NULL
species	NULL
of	NULL
Rb	NULL
isolated	NULL
from	NULL
human	NULL
tumors	NULL
can	NULL
no	NULL
longer	NULL
interact	NULL
with	NULL
E2F	NULL
(	NULL
15	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
Rb	NULL
to	NULL
suppress	NULL
cell	NULL
growth	NULL
in	NULL
some	NULL
assays	NULL
appears	NULL
to	NULL
correlate	NULL
with	NULL
its	NULL
capacity	NULL
to	NULL
bind	NULL
E2F	NULL
(	NULL
34	NULL
)	NULL
.	NULL

There	NULL
is	NULL
mounting	NULL
evidence	NULL
that	NULL
Rb-EZ2F	NULL
complexes	NULL
may	NULL
negatively	NULL
regulate	NULL
E2F	NULL
function	NULL
,	NULL
perhaps	NULL
by	NULL
sequestering	NULL
E2F	NULL
or	NULL
by	NULL
functioning	NULL
as	NULL
a	NULL
repressor	NULL
of	NULL
E2F-responsive	NULL
promoters	NULL
(	NULL
2	NULL
,	NULL
9	NULL
,	NULL
12	NULL
,	NULL
15	NULL
,	NULL
41	NULL
,	NULL
45	NULL
)	NULL
.	NULL

The	NULL
biological	NULL
activity	NULL
of	NULL
adenovirus	NULL
ElA	NULL
is	NULL
consistent	NULL
with	NULL
this	NULL
possibility	NULL
.	NULL

ElA	NULL
dissociates	NULL
Rb-E2F	NULL
complexes	NULL
,	NULL
releasing	NULL
unbound	NULL
or	NULL
free	NULL
E2F	NULL
,	NULL
which	NULL
is	NULL
then	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
adenovirus	NULL
E4	NULL
protein	NULL
and	NULL
transactivate	NULL
the	NULL
E2	NULL
promoter	NULL
(	NULL
1	NULL
)	NULL
.	NULL

ElA	NULL
sequences	NULL
necessary	NULL
for	NULL
dissociation	NULL
of	NULL
Rb-E2F	NULL
complexes	NULL
reside	NULL
within	NULL
conserved	NULL
region	NULL
2	NULL
.	NULL

These	NULL
sequences	NULL
are	NULL
also	NULL
required	NULL
for	NULL
direct	NULL
binding	NULL
to	NULL
Rb	NULL
and	NULL
for	NULL
E1lA-mediated	NULL
cell	NULL
transformation	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
capacity	NULL
to	NULL
disrupt	NULL
Rb-E2F	NULL
complexes	NULL
is	NULL
shared	NULL
by	NULL
two	NULL
additional	NULL
viral	NULL
transforming	NULL
proteins	NULL
which	NULL
interact	NULL
with	NULL
Rb	NULL
,	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
large	NULL
T	NULL
antigen	NULL
and	NULL
the	NULL
human	NULL
papillomavirus	NULL
E7	NULL
protein	NULL
(	NULL
7	NULL
,	NULL
32	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
E2F	NULL
is	NULL
a	NULL
common	NULL
cellular	NULL
target	NULL
of	NULL
DNA	NULL
tumor	NULL
viruses	NULL
.	NULL

The	NULL
Rb-related	NULL
protein	NULL
p107	NULL
forms	NULL
an	NULL
independent	NULL
complex	NULL
with	NULL
EZ2F	NULL
(	NULL
5	NULL
,	NULL
10	NULL
,	NULL
38	NULL
)	NULL
.	NULL

The	NULL
predominant	NULL
p107-E2F	NULL
complex	NULL
identified	NULL
in	NULL
cell	NULL
extracts	NULL
also	NULL
contains	NULL
cyclin	NULL
A	NULL
and	NULL
an	NULL
associated	NULL
kinase	NULL
,	NULL
cdk2	NULL
(	NULL
5	NULL
,	NULL
10	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Adenovirus	NULL
ElA	NULL
also	NULL
binds	NULL
p107	NULL
,	NULL
with	NULL
a	NULL
requirement	NULL
in	NULL
both	NULL
cases	NULL
for	NULL
ElA	NULL
conserved	NULL
region	NULL
2	NULL
sequences	NULL
(	NULL
42	NULL
)	NULL
,	NULL
and	NULL
it	NULL
can	NULL
also	NULL
dissociate	NULL
pl07-E2F	NULL
complexes	NULL
(	NULL
7	NULL
,	NULL
38	NULL
)	NULL
.	NULL

A	NULL
less	NULL
abundant	NULL
pl07-E2F	NULL
complex	NULL
,	NULL
containing	NULL
cyclin	NULL
E	NULL
and	NULL
cdk2	NULL
,	NULL
has	NULL
also	NULL
been	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

While	NULL
it	NULL
is	NULL
not	NULL
yet	NULL
known	NULL
how	NULL
these	NULL
interac-	NULL
3976	NULL
CHITTENDEN	NULL
tions	NULL
affect	NULL
E2F	NULL
function	NULL
,	NULL
the	NULL
association	NULL
of	NULL
E2F	NULL
with	NULL
components	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
machinery	NULL
likely	NULL
reflects	NULL
a	NULL
mechanism	NULL
linking	NULL
E2F	NULL
activity	NULL
with	NULL
its	NULL
suspected	NULL
role	NULL
in	NULL
cell	NULL
cycle	NULL
control	NULL
.	NULL

Analysis	NULL
of	NULL
E2F	NULL
complexes	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
has	NULL
shown	NULL
that	NULL
the	NULL
Rb-EZF	NULL
and	NULL
p107-E2F	NULL
complexes	NULL
are	NULL
differentially	NULL
regulated	NULL
.	NULL

The	NULL
p107-cyclin	NULL
A-E2F	NULL
complex	NULL
is	NULL
absent	NULL
in	NULL
G	NULL
,	NULL
and	NULL
is	NULL
detected	NULL
at	NULL
the	NULL
onset	NULL
of	NULL
S	NULL
phase	NULL
(	NULL
38	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
pl07-cyclin	NULL
E-E2F	NULL
complex	NULL
largely	NULL
appears	NULL
in	NULL
late	NULL
G	NULL
,	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
Rb-E2F	NULL
complex	NULL
is	NULL
present	NULL
in	NULL
G	NULL
,	NULL
and	NULL
in	NULL
S	NULL
(	NULL
38	NULL
)	NULL
.	NULL

There-fore	NULL
,	NULL
E2F	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
simply	NULL
handed	NULL
off	NULL
from	NULL
Rb	NULL
to	NULL
p107	NULL
as	NULL
a	NULL
cell	NULL
progresses	NULL
from	NULL
late	NULL
G	NULL
,	NULL
into	NULL
S.	NULL
To	NULL
better	NULL
understand	NULL
the	NULL
regulation	NULL
of	NULL
E2F	NULL
,	NULL
it	NULL
is	NULL
important	NULL
to	NULL
learn	NULL
which	NULL
species	NULL
of	NULL
E2F	NULL
are	NULL
present	NULL
at	NULL
certain	NULL
key	NULL
points	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

In	NULL
an	NULL
effort	NULL
to	NULL
address	NULL
this	NULL
question	NULL
,	NULL
we	NULL
have	NULL
attempted	NULL
to	NULL
identify	NULL
and	NULL
characterize	NULL
E2F	NULL
species	NULL
in	NULL
primary	NULL
,	NULL
diploid	NULL
human	NULL
cells	NULL
with	NULL
respect	NULL
to	NULL
their	NULL
composition	NULL
and	NULL
temporal	NULL
abundance	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
undertaken	NULL
a	NULL
more	NULL
detailed	NULL
analysis	NULL
of	NULL
both	NULL
predominant	NULL
and	NULL
less	NULL
abundant	NULL
E2F	NULL
DNA-binding	NULL
activities	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
from	NULL
healthy	NULL
donors	NULL
.	NULL

We	NULL
chose	NULL
to	NULL
perform	NULL
these	NULL
studies	NULL
with	NULL
primary	NULL
human	NULL
cells	NULL
since	NULL
,	NULL
unlike	NULL
most	NULL
established	NULL
cell	NULL
lines	NULL
,	NULL
these	NULL
cells	NULL
are	NULL
diploid	NULL
and	NULL
should	NULL
produce	NULL
wild-type	NULL
E2F	NULL
and	NULL
E2F-binding	NULL
partners	NULL
.	NULL

Our	NULL
analysis	NULL
has	NULL
identified	NULL
several	NULL
novel	NULL
EZF	NULL
complexes	NULL
,	NULL
one	NULL
of	NULL
which	NULL
is	NULL
restricted	NULL
to	NULL
Gy/G	NULL
,	NULL
and	NULL
appears	NULL
to	NULL
involve	NULL
an	NULL
interaction	NULL
with	NULL
a	NULL
heretofore	NULL
unrecognized	NULL
E2F-binding	NULL
protein	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
both	NULL
gel	NULL
shift	NULL
and	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
suggested	NULL
the	NULL
existence	NULL
of	NULL
biochemically	NULL
distinct	NULL
E2F	NULL
DNA-binding	NULL
species	NULL
,	NULL
at	NULL
least	NULL
one	NULL
of	NULL
which	NULL
interacts	NULL
with	NULL
p107	NULL
but	NULL
not	NULL
with	NULL
Rb	NULL
.	NULL

These	NULL
results	NULL
point	NULL
to	NULL
additional	NULL
levels	NULL
of	NULL
complexity	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
and	NULL
by	NULL
E2F	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Preparation	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
and	NULL
cell	NULL
extracts	NULL
.	NULL

Primary	NULL
human	NULL
T	NULL
lymphocytes	NULL
were	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
by	NULL
centrifugation	NULL
through	NULL
Ficoll-Hypaque	NULL
gradients	NULL
(	NULL
Pharmacia	NULL
)	NULL
.	NULL

Adherent	NULL
cells	NULL
were	NULL
depleted	NULL
from	NULL
these	NULL
preparations	NULL
by	NULL
incubation	NULL
on	NULL
plastic	NULL
dishes	NULL
for	NULL
at	NULL
least	NULL
2	NULL
h.	NULL
Cells	NULL
were	NULL
harvested	NULL
immediately	NULL
thereafter	NULL
for	NULL
preparation	NULL
of	NULL
whole	NULL
cell	NULL
extracts	NULL
.	NULL

In	NULL
some	NULL
cases	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
GIBCO	NULL
)	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
GIBCO	NULL
)	NULL
at	NULL
37Â°C	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
-containing	NULL
atmosphere	NULL
.	NULL

They	NULL
were	NULL
stimulated	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
phytohemagglutinin	NULL
(	NULL
1	NULL
mg/m	NULL
!	NULL
)	NULL

for	NULL
the	NULL
indicated	NULL
times	NULL
prior	NULL
to	NULL
being	NULL
extracted	NULL
.	NULL

Centrifugal	NULL
elutriation	NULL
of	NULL
T	NULL
cells	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
38	NULL
)	NULL
.	NULL

U937	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
suspension	NULL
in	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
27	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
.	NULL

DNA	NULL
binding	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
38	NULL
)	NULL
,	NULL
with	NULL
some	NULL
modifications	NULL
.	NULL

DNA	NULL
binding	NULL
reaction	NULL
mixtures	NULL
contained	NULL
20	NULL
pl	NULL
of	NULL
binding	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
KCI	NULL
,	NULL
20	NULL
mM	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
;	NULL
pH	NULL
7.6	NULL
]	NULL
,	NULL
10	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
sonicated	NULL
salmon	NULL
sperm	NULL
DNA	NULL
,	NULL
5	NULL
to	NULL
10	NULL
mg	NULL
of	NULL
whole	NULL
cell	NULL
extract	NULL
,	NULL
and	NULL
1	NULL
ng	NULL
of	NULL
**P-end-labeled	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
E2pro	NULL
;	NULL
see	NULL
below	NULL
}	NULL
.	NULL

Approximately	NULL
50	NULL
ng	NULL
of	NULL
the	NULL
relevant	NULL
purified	NULL
,	NULL
Escherichia	NULL
coli-synthesized	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
-E1A	NULL
and/or	NULL
GST-E4	NULL
fusion	NULL
protein	NULL
(	NULL
19	NULL
,	NULL
29	NULL
,	NULL
38	NULL
)	NULL
was	NULL
added	NULL
to	NULL
reactions	NULL
where	NULL
indicated	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
1	NULL
pl	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
of	NULL
purified	NULL
monoclonal	NULL
antibody	NULL
(	NULL
XZ55	NULL
or	NULL
C36	NULL
;	NULL
Pharmingen	NULL
)	NULL
or	NULL
1	NULL
wl	NULL
of	NULL
rabbit	NULL
polyclonal	NULL
antisera	NULL
(	NULL
anti-p107	NULL
,	NULL
N9	NULL
,	NULL
and	NULL
preimmune	NULL
;	NULL
[	NULL
38	NULL
]	NULL
)	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

was	NULL
added	NULL
to	NULL
DNA	NULL
binding	NULL
reactions	NULL
.	NULL

Affinity-purified	NULL
polyclonal	NULL
antiserum	NULL
to	NULL
E2F-1	NULL
(	NULL
19	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
W.	NULL
Krek	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
2	NULL
wl	NULL
of	NULL
monoclonal	NULL
antibody	NULL
tissue	NULL
culture	NULL
supernatant	NULL
SD4	NULL
,	NULL
$	NULL
D6	NULL
,	NULL
SD15	NULL
,	NULL
XZ140	NULL
,	NULL
HE111	NULL
,	NULL
or	NULL
423	NULL
was	NULL
added	NULL
.	NULL

The	NULL
p107	NULL
monoclonal	NULL
antibodies	NULL
SD4	NULL
,	NULL
SD6	NULL
,	NULL
and	NULL
SD15	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
N.	NULL
Dyson	NULL
and	NULL
E.	NULL
Harlow	NULL
(	NULL
10b	NULL
)	NULL
;	NULL
XZ140	NULL
and	NULL
HE111	NULL
were	NULL
the	NULL
kind	NULL
gifts	NULL
of	NULL
E.	NULL
Harlow	NULL
and	NULL
E.	NULL
Lees	NULL
,	NULL
respectively	NULL
.	NULL

Binding	NULL
reaction	NULL
mixtures	NULL
were	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
electrophoresis	NULL
at	NULL
300	NULL
V	NULL
and	NULL
4Â°C	NULL
in	NULL
4	NULL
%	NULL
polyacrylamide	NULL
,	NULL
0.25	NULL
%	NULL
Tris-borate-EDTA	NULL
gels	NULL
.	NULL

Oligonucleotides	NULL
.	NULL

The	NULL
DNA	NULL
sequences	NULL
of	NULL
the	NULL
E2F	NULL
DNA	NULL
binding	NULL
site	NULL
oligonucleotides	NULL
E2pro	NULL
,	NULL
DHFR	NULL
WT	NULL
,	NULL
and	NULL
DHFR	NULL
MUT	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
38	NULL
)	NULL
,	NULL
as	NULL
were	NULL
C9	NULL
and	NULL
BK	NULL
(	NULL
8	NULL
)	NULL
.	NULL

E2pro	NULL
,	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
in	NULL
E2F	NULL
DNA	NULL
binding	NULL
assays	NULL
,	NULL
contains	NULL
the	NULL
-70	NULL
to	NULL
-32	NULL
region	NULL
of	NULL
the	NULL
adenoviral	NULL
E2	NULL
promoter	NULL
,	NULL
encompassing	NULL
both	NULL
E2F	NULL
binding	NULL
sites	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
E2BDR	NULL
oligonucleotide	NULL
used	NULL
for	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
(	NULL
see	NULL
below	NULL
)	NULL
is	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
.	NULL

UV	NULL
cross-linking	NULL
of	NULL
E2F	NULL
complexes	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
by	NULL
Thompson	NULL
et	NULL
al	NULL
.	NULL

(	NULL
40	NULL
)	NULL
.	NULL

A	NULL
bromodeoxyuridine	NULL
(	NULL
BUdR	NULL
)	NULL
-substituted	NULL
probe	NULL
was	NULL
prepared	NULL
by	NULL
annealing	NULL
the	NULL
oligonucleotide	NULL
primer	NULL
E2BDR	NULL
with	NULL
the	NULL
plus	NULL
strand	NULL
of	NULL
E2pro	NULL
.	NULL

One	NULL
microgram	NULL
of	NULL
the	NULL
annealed	NULL
oligonucleotides	NULL
was	NULL
incubated	NULL
with	NULL
DNA	NULL
polymerase	NULL
I	NULL
(	NULL
Klenow	NULL
fragment	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.1	NULL
mM	NULL
each	NULL
dATP	NULL
,	NULL
dGTP	NULL
,	NULL
and	NULL
bromo-dUTP	NULL
(	NULL
Sigma	NULL
)	NULL
,	NULL
5	NULL
wM	NULL
dCTP	NULL
,	NULL
and	NULL
200	NULL
wCi	NULL
of	NULL
[	NULL
Â«	NULL
-	NULL
``	NULL
Â°P	NULL
]	NULL
dCTP	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
)	NULL
.	NULL

Unincorporated	NULL
nucleotides	NULL
were	NULL
removed	NULL
by	NULL
Sephadex	NULL
G-25	NULL
chromatogra-phy	NULL
.	NULL

EMSAs	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
BUdR-substituted	NULL
probe	NULL
(	NULL
10Â°	NULL
cpm	NULL
per	NULL
binding	NULL
reaction	NULL
)	NULL
as	NULL
described	NULL
above	NULL
except	NULL
that	NULL
the	NULL
amount	NULL
of	NULL
cell	NULL
extract	NULL
was	NULL
increased	NULL
twofold	NULL
.	NULL

Immediately	NULL
after	NULL
electrophoresis	NULL
,	NULL
the	NULL
wet	NULL
gel	NULL
was	NULL
covered	NULL
with	NULL
plastic	NULL
wrap	NULL
and	NULL
exposed	NULL
to	NULL
UV	NULL
light	NULL
(	NULL
500	NULL
mJ	NULL
)	NULL
with	NULL
a	NULL
Stratalinker	NULL
1800	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
various	NULL
EZ2F	NULL
complexes	NULL
were	NULL
determined	NULL
by	NULL
overnight	NULL
autoradiography	NULL
at	NULL
4Â°C	NULL
.	NULL

Gel	NULL
slices	NULL
containing	NULL
various	NULL
E2F	NULL
bands	NULL
were	NULL
excised	NULL
and	NULL
crushed	NULL
with	NULL
50	NULL
pl	NULL
of	NULL
2	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
sample	NULL
buffer	NULL
between	NULL
two	NULL
glass	NULL
slides	NULL
.	NULL

The	NULL
gel	NULL
slurries	NULL
were	NULL
then	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
and	NULL
electrophoresed	NULL
through	NULL
an	NULL
SDS-8	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
along	NULL
with	NULL
prestained	NULL
molecular	NULL
weight	NULL
markers	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

RESULTS	NULL
Identification	NULL
of	NULL
additional	NULL
E2F	NULL
DNA-binding	NULL
activities	NULL
in	NULL
unstimulated	NULL
T-cell	NULL
extracts	NULL
.	NULL

Previous	NULL
experiments	NULL
using	NULL
EMSA	NULL
led	NULL
to	NULL
the	NULL
identification	NULL
of	NULL
four	NULL
specific	NULL
E2F	NULL
activities	NULL
in	NULL
mitogen-stimulated	NULL
T	NULL
cells	NULL
(	NULL
38	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
stimulated	NULL
)	NULL
.	NULL

They	NULL
have	NULL
been	NULL
designated	NULL
complexes	NULL
C	NULL
,	NULL
B	NULL
,	NULL
A	NULL
,	NULL
and	NULL
A	NULL
'	NULL
.	NULL

It	NULL
was	NULL
previously	NULL
demonstrated	NULL
that	NULL
B	NULL
contains	NULL
E2F	NULL
bound	NULL
to	NULL
Rb	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
most	NULL
slowly	NULL
migrating	NULL
of	NULL
these	NULL
activities	NULL
,	NULL
C	NULL
,	NULL
is	NULL
composed	NULL
of	NULL
E2F	NULL
in	NULL
complex	NULL
with	NULL
the	NULL
Rb-related	NULL
protein	NULL
p107	NULL
and	NULL
cyclin	NULL
A	NULL
(	NULL
38	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
C	NULL
also	NULL
contains	NULL
the	NULL
kinase	NULL
edk2	NULL
,	NULL
which	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
component	NULL
of	NULL
a	NULL
similar	NULL
complex	NULL
found	NULL
in	NULL
other	NULL
human	NULL
cells	NULL
(	NULL
5	NULL
,	NULL
10	NULL
)	NULL
.	NULL

A	NULL
and	NULL
A	NULL
'	NULL
have	NULL
been	NULL
characterized	NULL
as	NULL
species	NULL
of	NULL
free	NULL
E2F	NULL
(	NULL
38	NULL
)	NULL
.	NULL

For	NULL
the	NULL
purpose	NULL
of	NULL
our	NULL
studies	NULL
,	NULL
``	NULL
free	NULL
``	NULL
``	NULL
is	NULL
defined	NULL
as	NULL
forms	NULL
of	NULL
E2F	NULL
that	NULL
are	NULL
free	NULL
to	NULL
interact	NULL
with	NULL
Rb	NULL
(	NULL
or	NULL
p107	NULL
)	NULL
and	NULL
the	NULL
adenovirus	NULL
E4	NULL
protein	NULL
in	NULL
gel	NULL
shift	NULL
assays	NULL
(	NULL
38	NULL
;	NULL
see	NULL
below	NULL
)	NULL
.	NULL

We	NULL
undertook	NULL
a	NULL
detailed	NULL
analysis	NULL
of	NULL
E2F	NULL
activities	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
with	NULL
particular	NULL
emphasis	NULL
on	NULL
resting	NULL
T	NULL
cells	NULL
.	NULL

In	NULL
unstimulated	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
arrested	NULL
in	NULL
G	NULL
,	NULL
,	NULL
we	NULL
detected	NULL
three	NULL
E2F	NULL
activities	NULL
(	NULL
labeled	NULL
X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
Z	NULL
)	NULL
with	NULL
gel	NULL
mobilities	NULL
distinct	NULL
from	NULL
those	NULL
of	NULL
the	NULL
previously	NULL
defined	NULL
species	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
the	NULL
activity	NULL
labeled	NULL
Z	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
unstimulated	NULL
3	NULL
I	NULL
sa	NULL
%	NULL
T	NULL
7	NULL
Â§	NULL
=	NULL
>	NULL
2	NULL
CC	NULL
&	NULL
C	NULL
s	NULL
u	NULL
u	NULL
t	NULL
x	NULL
%	NULL
%	NULL
a	NULL
competitor	NULL
houti	NULL
oB	NULL
KP	NULL
-	NULL
Â»	NULL
l	NULL
T	NULL
LLL	NULL
_L_	NULL
a	NULL
bnad	NULL
-	NULL
C	NULL
X	NULL
-	NULL
woud	NULL
bcd	NULL
boauk	NULL
jus	NULL
-B	NULL
y	NULL
&	NULL
-A	NULL
aug	NULL
!	NULL

has	NULL
*	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

E2F	NULL
DNA-binding	NULL
activities	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
.	NULL

Unstimulated	NULL
(	NULL
G	NULL
,	NULL
)	NULL
T-cell	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
indicated	NULL
competitor	NULL
oligonucleotides	NULL
(	NULL
~-	NULL
indicates	NULL
no	NULL
competitor	NULL
added	NULL
)	NULL
and	NULL
a	NULL
P-labeled	NULL
E2F	NULL
probe	NULL
(	NULL
the	NULL
E2pro	NULL
oligonu-cleotide	NULL
)	NULL
.	NULL

DHFR	NULL
WT	NULL
and	NULL
C9	NULL
encode	NULL
functional	NULL
E2F	NULL
binding	NULL
sites	NULL
.	NULL

DHFR	NULL
MUT	NULL
and	NULL
BK	NULL
encode	NULL
a	NULL
mutant	NULL
E2F	NULL
site	NULL
(	NULL
unable	NULL
to	NULL
bind	NULL
E2F	NULL
)	NULL
and	NULL
an	NULL
unrelated	NULL
DNA	NULL
sequence	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
reactions	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
Z	NULL
denote	NULL
specific	NULL
E2F	NULL
DNA-binding	NULL
species	NULL
.	NULL

E2F	NULL
DNA-binding	NULL
activities	NULL
present	NULL
in	NULL
T	NULL
cells	NULL
stimulated	NULL
for	NULL
40	NULL
h	NULL
(	NULL
complexes	NULL
C	NULL
,	NULL
B	NULL
,	NULL
A	NULL
,	NULL
and	NULL
A	NULL
'	NULL
)	NULL
were	NULL
analyzed	NULL
in	NULL
parallel	NULL
for	NULL
comparison	NULL
(	NULL
rightmost	NULL
lane	NULL
)	NULL
.	NULL

The	NULL
asterisks	NULL
in	NULL
all	NULL
figures	NULL
indicate	NULL
a	NULL
nonspecific	NULL
DNA-binding	NULL
activity	NULL
.	NULL

(	NULL
The	NULL
data	NULL
shown	NULL
in	NULL
the	NULL
lane	NULL
labeled	NULL
stimulated	NULL
are	NULL
also	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2C	NULL
[	NULL
lane	NULL
marked	NULL
stimulated	NULL
]	NULL
.	NULL

The	NULL
data	NULL
in	NULL
Figs	NULL
.	NULL

1	NULL
and	NULL
2C	NULL
are	NULL
all	NULL
derived	NULL
from	NULL
the	NULL
same	NULL
gel	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
the	NULL
stimulated	NULL
lane	NULL
was	NULL
cropped	NULL
from	NULL
the	NULL
picture	NULL
of	NULL
the	NULL
intact	NULL
gel	NULL
and	NULL
apposed	NULL
to	NULL
the	NULL
flanking	NULL
lanes	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

2C	NULL
,	NULL
they	NULL
remained	NULL
in	NULL
their	NULL
original	NULL
positions	NULL
in	NULL
the	NULL
picture	NULL
.	NULL
)	NULL

was	NULL
resolved	NULL
into	NULL
two	NULL
bands	NULL
(	NULL
see	NULL
also	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

The	NULL
most	NULL
prominent	NULL
species	NULL
,	NULL
X	NULL
,	NULL
had	NULL
been	NULL
noted	NULL
in	NULL
a	NULL
previous	NULL
study	NULL
but	NULL
was	NULL
not	NULL
characterized	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Competition	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
established	NULL
that	NULL
X	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
less	NULL
prominent	NULL
bands	NULL
Y	NULL
and	NULL
Z	NULL
,	NULL
result	NULL
from	NULL
specific	NULL
interactions	NULL
with	NULL
the	NULL
E2F	NULL
DNA	NULL
binding	NULL
site	NULL
.	NULL

X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
Z	NULL
all	NULL
disappeared	NULL
upon	NULL
the	NULL
addition	NULL
of	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
either	NULL
the	NULL
E2F	NULL
binding	NULL
site	NULL
within	NULL
the	NULL
DHFR	NULL
promoter	NULL
(	NULL
DHFR	NULL
WT	NULL
)	NULL
or	NULL
an	NULL
E2F	NULL
binding	NULL
site	NULL
isolated	NULL
by	NULL
an	NULL
in	NULL
vitro	NULL
binding	NULL
site	NULL
selection	NULL
strategy	NULL
(	NULL
C9	NULL
)	NULL
.	NULL

X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
Z	NULL
were	NULL
not	NULL
eliminated	NULL
by	NULL
an	NULL
oligonucleotide	NULL
of	NULL
unrelated	NULL
sequence	NULL
(	NULL
BK	NULL
)	NULL
or	NULL
by	NULL
a	NULL
DHFR	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutated	NULL
E2F	NULL
binding	NULL
site	NULL
(	NULL
DHFR	NULL
MUT	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
Z	NULL
are	NULL
all	NULL
specific	NULL
EZ2F	NULL
DNA-binding	NULL
activities	NULL
,	NULL
different	NULL
from	NULL
the	NULL
A'-C	NULL
set	NULL
predominant	NULL
in	NULL
stimulated	NULL
T-cell	NULL
extracts	NULL
.	NULL

X	NULL
and	NULL
Y	NULL
are	NULL
dissociated	NULL
by	NULL
adenovirus	NULL
E1A	NULL
and	NULL
appear	NULL
to	NULL
contain	NULL
different	NULL
forms	NULL
of	NULL
E2F	NULL
.	NULL

ElA	NULL
has	NULL
the	NULL
ability	NULL
to	NULL
dissociate	NULL
Rb-E2F	NULL
and	NULL
p107-E2F	NULL
complexes	NULL
(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
with	NULL
a	NULL
resulting	NULL
increase	NULL
in	NULL
free	NULL
E2F	NULL
(	NULL
1	NULL
,	NULL
7	NULL
,	NULL
38	NULL
)	NULL
.	NULL

This	NULL
activity	NULL
requires	NULL
ElA	NULL
sequences	NULL
necessary	NULL
for	NULL
binding	NULL
to	NULL
Rb	NULL
and	NULL
p107	NULL
(	NULL
E1A	NULL
conserved	NULL
region	NULL
2	NULL
)	NULL
.	NULL

We	NULL
wished	NULL
to	NULL
determine	NULL
whether	NULL
any	NULL
of	NULL
the	NULL
E2F	NULL
complexes	NULL
X	NULL
,	NULL
Y	NULL
,	NULL
and	NULL
Z	NULL
contained	NULL
Rb	NULL
,	NULL
p107	NULL
,	NULL
or	NULL
a	NULL
related	NULL
E1lA-binding	NULL
protein	NULL
.	NULL

T-cell	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
two	NULL
different	NULL
bacterially	NULL
expressed	NULL
GST-E1A	NULL
fusion	NULL
proteins	NULL
.	NULL

GST-E1A	NULL
976	NULL
contains	NULL
wild-type	NULL
E1A	NULL
sequences	NULL
(	NULL
residues	NULL
1	NULL
to	NULL
139	NULL
)	NULL
which	NULL
are	NULL
sufficient	NULL
for	NULL
Rb	NULL
and	NULL
p107	NULL
binding	NULL
and	NULL
disruption	NULL
of	NULL
Rb-E2F	NULL
and	NULL
p107-E2F	NULL
NOVEL	NULL
E2F	NULL
SPECIES	NULL
IN	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
3977	NULL
A	NULL
20	NULL
hr	NULL
B	NULL
40	NULL
hr	NULL
(	NULL
eee	NULL
ine	NULL
ena	NULL
+GST-E1A	NULL
+GST-E1A	NULL
g22	NULL
_	NULL
976	NULL
-	NULL
_	NULL
gee	NULL
_	NULL
are	NULL
n	NULL
<	NULL
4	NULL
a	NULL
#	NULL
68	NULL
lnoth	NULL
iB	NULL
cu..	NULL
Psd	NULL
Mie	NULL
cow	NULL
sil	NULL
cem	NULL
wat	NULL
bead	NULL
buut	NULL
bood	NULL
~6	NULL
ye	NULL
-B	NULL
bused	NULL
-	NULL
A	NULL
C	NULL
unstimulated	NULL
B	NULL
Al	NULL
oI	NULL
nsd	NULL
&	NULL
+GST-E1A	NULL
E	NULL
gas	NULL
off	NULL
%	NULL
nge	NULL
Sem	NULL
mos	NULL
fae	NULL
ons	NULL
sie	NULL
cars	NULL
ie	NULL
a	NULL
lil	NULL
-	NULL
c	NULL
E	NULL
:	NULL
wig	NULL
)	NULL
ho	NULL
wl	NULL
bused	NULL
X	NULL
-	NULL
unk	NULL
forn	NULL
foud	NULL
hug	NULL
bood	NULL
to	NULL
#	NULL
``	NULL
g	NULL
rge	NULL
:	NULL
-	NULL
A	NULL
-	NULL
A	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Dissociation	NULL
of	NULL
E2F	NULL
complexes	NULL
by	NULL
ElA	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
Analysis	NULL
of	NULL
extracts	NULL
prepared	NULL
from	NULL
G	NULL
,	NULL
and	NULL
S-phase	NULL
cells	NULL
.	NULL

T-cell	NULL
extracts	NULL
prepared	NULL
after	NULL
20	NULL
h	NULL
(	NULL
mostly	NULL
G	NULL
,	NULL
cells	NULL
)	NULL
or	NULL
40	NULL
h	NULL
(	NULL
containing	NULL
S-phase	NULL
cells	NULL
)	NULL
of	NULL
mitogen	NULL
stimulation	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
GST-E1A	NULL
fusion	NULL
proteins	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

The	NULL
reactions	NULL
were	NULL
then	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
mobilities	NULL
of	NULL
the	NULL
various	NULL
E2F-specific	NULL
activities	NULL
are	NULL
indicated	NULL
(	NULL
X	NULL
,	NULL
C	NULL
,	NULL
B	NULL
,	NULL
A	NULL
,	NULL
and	NULL
A	NULL
'	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Analysis	NULL
of	NULL
a	NULL
G	NULL
,	NULL
cell	NULL
extract	NULL
.	NULL

An	NULL
extract	NULL
prepared	NULL
from	NULL
unstimulated	NULL
human	NULL
T	NULL
cells	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
GST-E1A	NULL
fusion	NULL
proteins	NULL
as	NULL
described	NULL
above	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
rightmost	NULL
lane	NULL
shows	NULL
the	NULL
E2F	NULL
activities	NULL
detected	NULL
in	NULL
T	NULL
cells	NULL
40	NULL
h	NULL
after	NULL
mitogen	NULL
addition	NULL
.	NULL

complexes	NULL
(	NULL
38	NULL
)	NULL
.	NULL

GST-E1A	NULL
922	NULL
harbors	NULL
a	NULL
mutation	NULL
within	NULL
E1A	NULL
conserved	NULL
region	NULL
2	NULL
(	NULL
residues	NULL
122	NULL
to	NULL
129	NULL
deleted	NULL
)	NULL
which	NULL
greatly	NULL
reduces	NULL
binding	NULL
to	NULL
Rb	NULL
and	NULL
p107	NULL
as	NULL
well	NULL
as	NULL
the	NULL
ability	NULL
to	NULL
dissociate	NULL
Rb-E2F	NULL
and	NULL
p107-E2F	NULL
complexes	NULL
(	NULL
38	NULL
)	NULL
.	NULL

To	NULL
test	NULL
the	NULL
biological	NULL
activity	NULL
of	NULL
these	NULL
E1A	NULL
fusion	NULL
proteins	NULL
,	NULL
a	NULL
T-cell	NULL
extract	NULL
prepared	NULL
40	NULL
h	NULL
after	NULL
mitogen	NULL
stimulation	NULL
was	NULL
incubated	NULL
with	NULL
equal	NULL
quantities	NULL
of	NULL
GST-E1A	NULL
976	NULL
and	NULL
922	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

As	NULL
has	NULL
been	NULL
demonstrated	NULL
previously	NULL
(	NULL
38	NULL
)	NULL
,	NULL
the	NULL
wild-type	NULL
(	NULL
976	NULL
)	NULL
but	NULL
not	NULL
the	NULL
mutant	NULL
(	NULL
922	NULL
)	NULL
E1A	NULL
protein	NULL
dissociated	NULL
both	NULL
Rb-E2F	NULL
and	NULL
p107-E2F	NULL
complexes	NULL
(	NULL
bands	NULL
B	NULL
and	NULL
C	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
an	NULL
increase	NULL
in	NULL
free	NULL
EZ2F	NULL
(	NULL
consisting	NULL
largely	NULL
of	NULL
A	NULL
)	NULL
.	NULL

X	NULL
predominates	NULL
in	NULL
unstimulated	NULL
T-cell	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
and	NULL
continues	NULL
to	NULL
be	NULL
the	NULL
most	NULL
abundant	NULL
E2F	NULL
activity	NULL
until	NULL
a	NULL
significant	NULL
number	NULL
of	NULL
cells	NULL
have	NULL
entered	NULL
S	NULL
phase	NULL
(	NULL
>	NULL
24	NULL
h	NULL
after	NULL
3978	NULL
-	NULL
CHITTENDEN	NULL
stimulation	NULL
;	NULL
see	NULL
below	NULL
)	NULL
.	NULL

A	NULL
T-cell	NULL
extract	NULL
prepared	NULL
20	NULL
h	NULL
(	NULL
late	NULL
G	NULL
,	NULL
)	NULL
after	NULL
mitogen	NULL
stimulation	NULL
was	NULL
incubated	NULL
with	NULL
either	NULL
purified	NULL
wild-type	NULL
GST-E1A	NULL
976	NULL
or	NULL
mutant	NULL
GST-E1A	NULL
922	NULL
protein	NULL
and	NULL
then	NULL
analyzed	NULL
by	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Treatment	NULL
with	NULL
wild-type	NULL
GST-E1A	NULL
976	NULL
diminished	NULL
X	NULL
with	NULL
a	NULL
corresponding	NULL
increase	NULL
in	NULL
A	NULL
,	NULL
a	NULL
species	NULL
of	NULL
free	NULL
E2F	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

The	NULL
mutant	NULL
GST-E1A	NULL
922	NULL
protein	NULL
did	NULL
not	NULL
have	NULL
this	NULL
effect	NULL
.	NULL

The	NULL
degree	NULL
to	NULL
which	NULL
X	NULL
was	NULL
diminished	NULL
by	NULL
wild-type	NULL
ElA	NULL
varied	NULL
between	NULL
experiments	NULL
,	NULL
with	NULL
typically	NULL
a	NULL
30	NULL
to	NULL
50	NULL
%	NULL
decrease	NULL
.	NULL

In	NULL
experiments	NULL
in	NULL
which	NULL
the	NULL
E1A	NULL
sensitivity	NULL
of	NULL
X	NULL
was	NULL
less	NULL
pronounced	NULL
than	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
B	NULL
,	NULL
there	NULL
was	NULL
a	NULL
correspondingly	NULL
less	NULL
dramatic	NULL
increase	NULL
in	NULL
band	NULL
A	NULL
intensity	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
imply	NULL
that	NULL
X	NULL
contains	NULL
a	NULL
species	NULL
of	NULL
E2F	NULL
(	NULL
corresponding	NULL
to	NULL
A	NULL
)	NULL
associated	NULL
with	NULL
a	NULL
cellular	NULL
ElA-binding	NULL
protein	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
GST-E1A	NULL
922	NULL
to	NULL
dissociate	NULL
X	NULL
suggests	NULL
that	NULL
this	NULL
protein	NULL
may	NULL
be	NULL
Rb	NULL
,	NULL
p107	NULL
,	NULL
or	NULL
another	NULL
protein	NULL
which	NULL
binds	NULL
to	NULL
E1A	NULL
conserved	NULL
region	NULL
2	NULL
.	NULL

The	NULL
minor	NULL
E2F	NULL
activities	NULL
,	NULL
Y	NULL
and	NULL
Z	NULL
,	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
B	NULL
but	NULL
only	NULL
after	NULL
longer	NULL
exposures	NULL
.	NULL

The	NULL
E1A	NULL
sensitivity	NULL
of	NULL
Y	NULL
and	NULL
Z	NULL
was	NULL
examined	NULL
by	NULL
similar	NULL
experiments	NULL
using	NULL
unstimulated	NULL
T-cell	NULL
extracts	NULL
,	NULL
in	NULL
which	NULL
these	NULL
complexes	NULL
were	NULL
easier	NULL
to	NULL
detect	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

In	NULL
all	NULL
experiments	NULL
,	NULL
Z	NULL
appeared	NULL
to	NULL
be	NULL
unaffected	NULL
by	NULL
incubation	NULL
with	NULL
ElA	NULL
.	NULL

However	NULL
,	NULL
the	NULL
second	NULL
minor	NULL
E2F	NULL
species	NULL
,	NULL
Y	NULL
,	NULL
was	NULL
entirely	NULL
sensitive	NULL
to	NULL
wild-type	NULL
but	NULL
not	NULL
mutant	NULL
ElA	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

The	NULL
ElA-induced	NULL
dissociation	NULL
of	NULL
Y	NULL
correlated	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
new	NULL
E2F	NULL
DNA-binding	NULL
activity	NULL
,	NULL
labeled	NULL
A	NULL
``	NULL
,	NULL
characterized	NULL
by	NULL
a	NULL
gel	NULL
moblhty	NULL
faster	NULL
than	NULL
that	NULL
of	NULL
the	NULL
previously	NULL
defined	NULL
E2F	NULL
species	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
Y	NULL
is	NULL
composed	NULL
of	NULL
a	NULL
biochemically	NULL
distinct	NULL
form	NULL
of	NULL
E2F	NULL
(	NULL
A	NULL
``	NULL
)	NULL
associated	NULL
with	NULL
a	NULL
cellular	NULL
E1A-binding	NULL
protein	NULL
.	NULL

As	NULL
in	NULL
the	NULL
case	NULL
of	NULL
X	NULL
,	NULL
ElA	NULL
conserved	NULL
region	NULL
2	NULL
sequences	NULL
were	NULL
required	NULL
for	NULL
ElA	NULL
dissociation	NULL
of	NULL
Y	NULL
,	NULL
again	NULL
implicating	NULL
Rb	NULL
,	NULL
p107	NULL
,	NULL
or	NULL
a	NULL
related	NULL
E1A-binding	NULL
protein	NULL
as	NULL
an	NULL
E2F-binding	NULL
protein	NULL
in	NULL
this	NULL
complex	NULL
.	NULL

Additional	NULL
experiments	NULL
were	NULL
performed	NULL
to	NULL
characterize	NULL
A	NULL
``	NULL
.	NULL

Typically	NULL
,	NULL
A	NULL
``	NULL
was	NULL
either	NULL
not	NULL
detectable	NULL
or	NULL
present	NULL
in	NULL
very	NULL
low	NULL
levels	NULL
in	NULL
untreated	NULL
T-cell	NULL
extracts	NULL
and	NULL
was	NULL
prominent	NULL
only	NULL
following	NULL
incubation	NULL
with	NULL
ElA	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
A	NULL
``	NULL
is	NULL
indeed	NULL
a	NULL
form	NULL
of	NULL
free	NULL
E2F	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
A	NULL
``	NULL
to	NULL
bind	NULL
a	NULL
bacterially	NULL
synthesized	NULL
GST-E4	NULL
protein	NULL
.	NULL

An	NULL
unstimulated	NULL
T-cell	NULL
extract	NULL
was	NULL
treated	NULL
with	NULL
wild-type	NULL
GST-E1A	NULL
976	NULL
to	NULL
generate	NULL
sufficient	NULL
levels	NULL
of	NULL
A	NULL
``	NULL
for	NULL
analysis	NULL
.	NULL

The	NULL
ElA-treated	NULL
extracts	NULL
were	NULL
also	NULL
incubated	NULL
with	NULL
either	NULL
wild-type	NULL
(	NULL
GST-E4	NULL
)	NULL
,	NULL
or	NULL
mutant	NULL
(	NULL
GST-E4A14-15	NULL
)	NULL
fusion	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

GST-E4A14-15	NULL
contains	NULL
a	NULL
small	NULL
C-terminal	NULL
deletion	NULL
that	NULL
abolishes	NULL
the	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
E2F	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
wild-type	NULL
E4	NULL
(	NULL
but	NULL
not	NULL
the	NULL
mutant	NULL
form	NULL
)	NULL
resulted	NULL
in	NULL
an	NULL
apparent	NULL
supershift	NULL
of	NULL
A	NULL
``	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
small	NULL
amount	NULL
of	NULL
A	NULL
generated	NULL
by	NULL
ElA	NULL
(	NULL
presumably	NULL
from	NULL
the	NULL
partial	NULL
dissociation	NULL
of	NULL
X	NULL
)	NULL
was	NULL
also	NULL
supershifted	NULL
by	NULL
wild-type	NULL
GST-E4	NULL
.	NULL

Thus	NULL
,	NULL
by	NULL
the	NULL
criteria	NULL
of	NULL
adenovirus	NULL
E4-binding	NULL
capacity	NULL
,	NULL
A	NULL
``	NULL
is	NULL
a	NULL
third	NULL
species	NULL
of	NULL
free	NULL
E2F	NULL
(	NULL
in	NULL
addition	NULL
to	NULL
A	NULL
and	NULL
A	NULL
'	NULL
)	NULL
.	NULL

Y	NULL
is	NULL
a	NULL
novel	NULL
Rb-E2F	NULL
complex	NULL
.	NULL

The	NULL
observed	NULL
dissociation	NULL
of	NULL
X	NULL
and	NULL
Y	NULL
by	NULL
E1A	NULL
with	NULL
a	NULL
requirement	NULL
for	NULL
conserved	NULL
region	NULL
2	NULL
raised	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
either	NULL
of	NULL
these	NULL
E2F	NULL
complexes	NULL
contained	NULL
Rb	NULL
or	NULL
p107	NULL
.	NULL

We	NULL
tested	NULL
whether	NULL
a	NULL
variety	NULL
of	NULL
Rb	NULL
and	NULL
p107	NULL
antibodies	NULL
could	NULL
perturb	NULL
X	NULL
or	NULL
Y	NULL
in	NULL
an	NULL
unstimulated	NULL
T-cell	NULL
extract	NULL
by	NULL
EMSA	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
several	NULL
different	NULL
Rb	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
XZ140	NULL
,	NULL
XZ55	NULL
,	NULL
and	NULL
C36	NULL
)	NULL
or	NULL
a	NULL
polyclonal	NULL
anti-Rb	NULL
antiserum	NULL
(	NULL
N9	NULL
)	NULL
supershifted	NULL
or	NULL
ablated	NULL
Y	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
Rb	NULL
is	NULL
a	NULL
component	NULL
of	NULL
complex	NULL
Y	NULL
.	NULL

These	NULL
antibodies	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
perturb	NULL
Rb-E2F	NULL
complex	NULL
B	NULL
(	NULL
reference	NULL
38	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
;	NULL
however	NULL
,	NULL
they	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
complex	NULL
X.	NULL
Incubation	NULL
with	NULL
several	NULL
p107	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
SD4	NULL
,	NULL
$	NULL
D6	NULL
,	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

976	NULL
+	NULL
GST-E4A14-15	NULL
csr	NULL
Â¥.48	NULL
&	NULL
g	NULL
GST-E1A	NULL
:	NULL
__	NULL
8	NULL
.	NULL

5	NULL
5	NULL
x	NULL
w	NULL
i-Fe	NULL
O	NULL
+	NULL
w	NULL
m	NULL
&	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Interaction	NULL
of	NULL
the	NULL
E2F	NULL
species	NULL
A	NULL
``	NULL
with	NULL
adenovirus	NULL
E4	NULL
protein	NULL
.	NULL

An	NULL
unstimulated	NULL
T-cell	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
wild-type	NULL
(	NULL
976	NULL
)	NULL
or	NULL
mutant	NULL
(	NULL
922	NULL
)	NULL
GST-E1A	NULL
fusion	NULL
protein	NULL
(	NULL
-	NULL
indicates	NULL
no	NULL
fusion	NULL
protein	NULL
added	NULL
)	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
a	NULL
GST-E4	NULL
fusion	NULL
protein	NULL
representing	NULL
either	NULL
a	NULL
wild-type	NULL
(	NULL
GST-E4	NULL
)	NULL
or	NULL
a	NULL
mutant	NULL
E4	NULL
protein	NULL
unable	NULL
to	NULL
interact	NULL
with	NULL
E2F	NULL
(	NULL
GST-E4A14-15	NULL
)	NULL
was	NULL
also	NULL
added	NULL
to	NULL
the	NULL
binding	NULL
reactions	NULL
.	NULL

E2F	NULL
activities	NULL
were	NULL
then	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

and	NULL
SD15	NULL
)	NULL
which	NULL
recognize	NULL
different	NULL
epitopes	NULL
within	NULL
p107	NULL
(	NULL
10a	NULL
)	NULL
or	NULL
with	NULL
polyclonal	NULL
anti-p107	NULL
antiserum	NULL
had	NULL
no	NULL
discernible	NULL
effect	NULL
on	NULL
either	NULL
X	NULL
or	NULL
Y	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

In	NULL
an	NULL
experiment	NULL
performed	NULL
in	NULL
parallel	NULL
,	NULL
these	NULL
p107	NULL
antibodies	NULL
were	NULL
able	NULL
to	NULL
supershift	NULL
C	NULL
,	NULL
the	NULL
S-phase-specific	NULL
p107	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
.	NULL

As	NULL
noted	NULL
previously	NULL
(	NULL
38	NULL
)	NULL
,	NULL
a	NULL
nonspecific	NULL
DNA-binding	NULL
activity	NULL
appeared	NULL
upon	NULL
the	NULL
addition	NULL
of	NULL
all	NULL
polyclonal	NULL
antisera	NULL
,	NULL
including	NULL
preimmune	NULL
serum	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
,	NULL
lane	NULL
P.I	NULL
.	NULL
)	NULL

,	NULL
migrating	NULL
A	NULL
a	NULL
Unstimulated	NULL
B	NULL
Stimulated	NULL
<	NULL
5	NULL
5	NULL
5	NULL
-	NULL
o	NULL
a	NULL
a	NULL
a	NULL
.	NULL

Â©	NULL
Â¥	NULL
i	NULL
w	NULL
a	NULL
.	NULL

4	NULL
&	NULL
a	NULL
%	NULL
Â©	NULL
Lon	NULL
#	NULL
Â®	NULL
s	NULL
%	NULL
#	NULL
nog	NULL
=	NULL
:	NULL
a	NULL
A	NULL
o	NULL
N	NULL
N	NULL
@	NULL
Â®	NULL
a	NULL
o	NULL
o	NULL
a	NULL
8	NULL
5	NULL
9	NULL
}	NULL
o	NULL
a	NULL
ao	NULL
x	NULL
x	NULL
0	NULL
2	NULL
T	NULL
a	NULL
a	NULL
a	NULL
Â§	NULL
L.	NULL
E	NULL
1	NULL
62	NULL
ame	NULL
a	NULL
Â«	NULL
-	NULL
gag	NULL
-	NULL
yon	NULL
wad	NULL
-	NULL
B	NULL
yapdngâA	NULL
loud	NULL
hid	NULL
Balt	NULL
)	NULL
-	NULL
a	NULL
'	NULL
+	NULL
Whore	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Rb	NULL
and	NULL
p107	NULL
antibody	NULL
perturbation	NULL
experiments	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
from	NULL
either	NULL
unstimulated	NULL
(	NULL
A	NULL
)	NULL
or	NULL
mitogen-stimulated	NULL
(	NULL
B	NULL
)	NULL
T	NULL
cells	NULL
.	NULL

They	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
antibodies	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

XZ140	NULL
,	NULL
XZ55	NULL
,	NULL
and	NULL
C36	NULL
are	NULL
monoclonal	NULL
antibodies	NULL
directed	NULL
against	NULL
Rb	NULL
;	NULL
SD4	NULL
,	NULL
SD6	NULL
,	NULL
and	NULL
SD15	NULL
are	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
p107	NULL
;	NULL
423	NULL
is	NULL
a	NULL
monoclonal	NULL
antibody	NULL
raised	NULL
against	NULL
simian	NULL
virus	NULL
40	NULL
large	NULL
T	NULL
antigen	NULL
;	NULL
N9	NULL
is	NULL
a	NULL
rabbit	NULL
anti-Rb	NULL
polyclonal	NULL
antiserum	NULL
.	NULL

A	NULL
rabbit	NULL
anti-p107	NULL
polyclonal	NULL
antiserum	NULL
and	NULL
an	NULL
affinity-purified	NULL
preparation	NULL
(	NULL
anti-p107	NULL
A.P	NULL
.	NULL
)	NULL

were	NULL
also	NULL
tested	NULL
.	NULL

-	NULL
,	NULL
no	NULL
antibody	NULL
;	NULL
P.I	NULL
.	NULL

,	NULL
preimmune	NULL
rabbit	NULL
antiserum	NULL
.	NULL

Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
A	NULL
B	NULL
0	NULL
0	NULL
5	NULL
.	NULL

5	NULL
.-6	NULL
Eo	NULL
k	NULL
Â¢	NULL
&	NULL
a	NULL
Â£	NULL
8	NULL
6Â°	NULL
#	NULL
.m	NULL
6	NULL
#	NULL
&	NULL
5	NULL
s	NULL
&	NULL
5	NULL
a	NULL
.	NULL

(	NULL
M	NULL
grotto	NULL
grows	NULL
grok	NULL
~~+	NULL
mas	NULL
est	NULL
veep	NULL
â	NULL
L	NULL
sq	NULL
;	NULL
+	NULL
hâA	NULL
NOVEL	NULL
E2F	NULL
SPECIES	NULL
IN	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
3979	NULL
Cas	NULL
D	NULL
:	NULL
``	NULL
g	NULL
S	NULL
&	NULL
-	NULL
Â§	NULL
<	NULL
Â£	NULL
Â«	NULL
&	NULL
E	NULL
&	NULL
ar	NULL
&	NULL
u	NULL
â¬	NULL
d	NULL
5	NULL
6	NULL
Â°	NULL
Z	NULL
6	NULL
#	NULL
Â©	NULL
m	NULL
C	NULL
mE	NULL
â¬	NULL
-Â£	NULL
Rd	NULL
Q.	NULL
a	NULL
a.	NULL
a	NULL
9	NULL
}	NULL
I	NULL
Â«	NULL
14	NULL
Shit	NULL
atee	NULL
ron	NULL
(	NULL
lly	NULL
a	NULL
on	NULL
Â»	NULL
>	NULL
DxO	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
antibodies	NULL
against	NULL
E2F-1	NULL
and	NULL
cyclin	NULL
E	NULL
on	NULL
E2F	NULL
complexes	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
Unstimulated	NULL
T	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Extracts	NULL
were	NULL
prepared	NULL
from	NULL
resting	NULL
T	NULL
cells	NULL
,	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
antibodies	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Anti-E2F-1	NULL
is	NULL
an	NULL
affinity-purified	NULL
polyclonal	NULL
rabbit	NULL
antibody	NULL
directed	NULL
against	NULL
E2F-1	NULL
,	NULL
HE111	NULL
is	NULL
a	NULL
cyclin	NULL
E	NULL
monoclonal	NULL
antibody	NULL
,	NULL
and	NULL
423	NULL
recognizes	NULL
simian	NULL
virus	NULL
40	NULL
large	NULL
T	NULL
antigen	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Extracts	NULL
were	NULL
also	NULL
incubated	NULL
with	NULL
the	NULL
wild-type	NULL
ELA	NULL
fusion	NULL
protein	NULL
GST-E1A	NULL
976	NULL
along	NULL
with	NULL
the	NULL
indicated	NULL
antibodies	NULL
.	NULL

(	NULL
C	NULL
and	NULL
D	NULL
)	NULL
Stimulated	NULL
T	NULL
cells	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
48	NULL
h	NULL
after	NULL
mitogen	NULL
stimulation	NULL
,	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
antibodies	NULL
(	NULL
see	NULL
above	NULL
)	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Two	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

-	NULL
,	NULL
no	NULL
antibody	NULL
.	NULL

just	NULL
above	NULL
complex	NULL
Z	NULL
.	NULL

Although	NULL
it	NULL
remains	NULL
possible	NULL
that	NULL
the	NULL
epitopes	NULL
for	NULL
these	NULL
antibodies	NULL
are	NULL
masked	NULL
specifically	NULL
in	NULL
complex	NULL
X	NULL
,	NULL
we	NULL
postulate	NULL
that	NULL
X	NULL
contains	NULL
an	NULL
ElA-binding	NULL
protein	NULL
other	NULL
than	NULL
Rb	NULL
or	NULL
p107	NULL
.	NULL

E2F-1	NULL
is	NULL
a	NULL
component	NULL
of	NULL
free	NULL
E2F	NULL
species	NULL
A	NULL
'	NULL
.	NULL

A	NULL
cDNA	NULL
encoding	NULL
a	NULL
protein	NULL
with	NULL
the	NULL
expected	NULL
properties	NULL
of	NULL
EZ2F	NULL
(	NULL
designated	NULL
E2F-1	NULL
)	NULL
has	NULL
recently	NULL
been	NULL
cloned	NULL
(	NULL
13	NULL
,	NULL
19	NULL
,	NULL
37	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
E2F-1	NULL
is	NULL
present	NULL
in	NULL
any	NULL
of	NULL
the	NULL
E2F	NULL
complexes	NULL
identified	NULL
here	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
a	NULL
polyclonal	NULL
antibody	NULL
raised	NULL
against	NULL
E2F-1	NULL
could	NULL
perturb	NULL
any	NULL
of	NULL
the	NULL
T-cell	NULL
E2F	NULL
activities	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

None	NULL
of	NULL
the	NULL
E2F	NULL
complexes	NULL
detected	NULL
in	NULL
unstimulated	NULL
T-cell	NULL
extracts	NULL
reacted	NULL
with	NULL
the	NULL
anti-E2F-1	NULL
antiserum	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Free	NULL
E2F	NULL
species	NULL
A	NULL
``	NULL
,	NULL
generated	NULL
by	NULL
ElA	NULL
treatment	NULL
of	NULL
an	NULL
unstimulated	NULL
T-cell	NULL
extract	NULL
,	NULL
also	NULL
was	NULL
unaffected	NULL
by	NULL
the	NULL
anti-E2F-1	NULL
antibody	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
stimulated	NULL
T-cell	NULL
extracts	NULL
,	NULL
the	NULL
anti-E2F-1	NULL
antiserum	NULL
consistently	NULL
eliminated	NULL
free	NULL
E2F	NULL
species	NULL
A	NULL
'	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
and	NULL
D	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
previous	NULL
results	NULL
(	NULL
19	NULL
)	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
complex	NULL
B	NULL
also	NULL
appeared	NULL
to	NULL
be	NULL
at	NULL
least	NULL
partly	NULL
affected	NULL
by	NULL
the	NULL
anti-E2F-1	NULL
antibody	NULL
(	NULL
19	NULL
)	NULL
;	NULL
however	NULL
,	NULL
this	NULL
effect	NULL
appeared	NULL
to	NULL
vary	NULL
between	NULL
different	NULL
cell	NULL
extracts	NULL
.	NULL

Nevertheless	NULL
,	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
E2F-1	NULL
is	NULL
a	NULL
component	NULL
of	NULL
only	NULL
one	NULL
(	NULL
A	NULL
'	NULL
)	NULL
of	NULL
the	NULL
three	NULL
free	NULL
E2F	NULL
species	NULL
identified	NULL
here	NULL
.	NULL

A	NULL
cell	NULL
cycle-dependent	NULL
interaction	NULL
between	NULL
cyclin	NULL
E	NULL
and	NULL
E2F	NULL
has	NULL
recently	NULL
been	NULL
described	NULL
(	NULL
22	NULL
)	NULL
,	NULL
raising	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
cyclin	NULL
E	NULL
is	NULL
present	NULL
in	NULL
any	NULL
of	NULL
the	NULL
T-cell	NULL
E2F	NULL
complexes	NULL
.	NULL

A	NULL
monoclonal	NULL
antibody	NULL
against	NULL
cyclin	NULL
E	NULL
(	NULL
HE111	NULL
)	NULL
failed	NULL
to	NULL
supershift	NULL
or	NULL
alter	NULL
any	NULL
of	NULL
the	NULL
E2F	NULL
species	NULL
detected	NULL
by	NULL
EMSA	NULL
in	NULL
unstimulated	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
or	NULL
stimulated	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
)	NULL
T-cell	NULL
extracts	NULL
.	NULL

The	NULL
Hell1	NULL
antibody	NULL
can	NULL
supershift	NULL
an	NULL
E2F	NULL
activity	NULL
in	NULL
other	NULL
cell	NULL
extracts	NULL
(	NULL
21a	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
with	NULL
HE111	NULL
,	NULL
followed	NULL
by	NULL
EMSA	NULL
analysis	NULL
of	NULL
detergent-released	NULL
associated	NULL
proteins	NULL
,	NULL
revealed	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
associated	NULL
E2F	NULL
in	NULL
stimulated	NULL
T-cell	NULL
extracts	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
the	NULL
antibody	NULL
can	NULL
react	NULL
with	NULL
cyclin	NULL
E	NULL
in	NULL
complex	NULL
with	NULL
E2F	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
we	NULL
were	NULL
able	NULL
to	NULL
detect	NULL
an	NULL
interaction	NULL
between	NULL
EZF	NULL
and	NULL
cyclin	NULL
E	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
this	NULL
may	NULL
be	NULL
a	NULL
complex	NULL
of	NULL
very	NULL
low	NULL
abundance	NULL
.	NULL

Different	NULL
E2F	NULL
complexes	NULL
and	NULL
free	NULL
E2F	NULL
species	NULL
exhibit	NULL
distinct	NULL
cell	NULL
cycle	NULL
behaviors	NULL
.	NULL

We	NULL
examined	NULL
whether	NULL
the	NULL
levels	NULL
of	NULL
the	NULL
various	NULL
EZF	NULL
species	NULL
described	NULL
above	NULL
vary	NULL
throughout	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

In	NULL
one	NULL
approach	NULL
,	NULL
resting	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
mitogens	NULL
and	NULL
E2F	NULL
complexes	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
at	NULL
various	NULL
times	NULL
later	NULL
as	NULL
the	NULL
cells	NULL
exited	NULL
G	NULL
,	NULL
and	NULL
entered	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Figure	NULL
6A	NULL
shows	NULL
an	NULL
experiment	NULL
in	NULL
which	NULL
resting	NULL
T	NULL
cells	NULL
(	NULL
0	NULL
h	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
mitogens	NULL
and	NULL
extracts	NULL
were	NULL
prepared	NULL
at	NULL
20	NULL
or	NULL
40	NULL
h	NULL
later	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
results	NULL
(	NULL
38	NULL
)	NULL
,	NULL
the	NULL
p107	NULL
complex	NULL
C	NULL
appeared	NULL
only	NULL
after	NULL
cells	NULL
had	NULL
entered	NULL
S	NULL
phase	NULL
(	NULL
40	NULL
h	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
38	NULL
)	NULL
,	NULL
the	NULL
Rb-E2F	NULL
complex	NULL
B	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
0	NULL
h	NULL
,	NULL
G	NULL
,	NULL
,	NULL
)	NULL
,	NULL
was	NULL
present	NULL
at	NULL
low	NULL
levels	NULL
at	NULL
20	NULL
h	NULL
(	NULL
predominantly	NULL
G	NULL
,	NULL
)	NULL
,	NULL
and	NULL
was	NULL
prominent	NULL
at	NULL
the	NULL
40-h	NULL
time	NULL
point	NULL
(	NULL
entry	NULL
into	NULL
S	NULL
)	NULL
.	NULL

The	NULL
minor	NULL
Rb-E2F	NULL
complex	NULL
,	NULL
Y	NULL
,	NULL
was	NULL
present	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
0	NULL
h	NULL
;	NULL
Fig	NULL
.	NULL

6A	NULL
[	NULL
seen	NULL
better	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
and	NULL
2C	NULL
)	NULL
)	NULL
;	NULL
thus	NULL
,	NULL
the	NULL
two	NULL
Rb-E2F	NULL
complexes	NULL
display	NULL
somewhat	NULL
different	NULL
temporal	NULL
regulation	NULL
.	NULL

Because	NULL
of	NULL
the	NULL
abundance	NULL
of	NULL
other	NULL
complexes	NULL
migrating	NULL
nearby	NULL
,	NULL
it	NULL
was	NULL
difficult	NULL
to	NULL
determine	NULL
whether	NULL
Y	NULL
and	NULL
Z	NULL
persisted	NULL
through	NULL
G	NULL
;	NULL
and/or	NULL
into	NULL
S.	NULL
The	NULL
two	NULL
major	NULL
species	NULL
of	NULL
free	NULL
E2F	NULL
,	NULL
A	NULL
and	NULL
A	NULL
'	NULL
,	NULL
displayed	NULL
quite	NULL
different	NULL
cell	NULL
cycle	NULL
kinetics	NULL
.	NULL

A	NULL
'	NULL
was	NULL
not	NULL
detected	NULL
until	NULL
cells	NULL
entered	NULL
S	NULL
phase	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
40	NULL
h	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
to	NULL
A	NULL
'	NULL
,	NULL
A	NULL
was	NULL
readily	NULL
detectable	NULL
at	NULL
earlier	NULL
times	NULL
(	NULL
20	NULL
h	NULL
)	NULL
.	NULL

Indeed	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
detect	NULL
A	NULL
as	NULL
early	NULL
as	NULL
6	NULL
h	NULL
after	NULL
mitogen	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

While	NULL
A	NULL
was	NULL
not	NULL
detected	NULL
at	NULL
0	NULL
h	NULL
,	NULL
it	NULL
could	NULL
be	NULL
generated	NULL
in	NULL
unstimulated	NULL
cell	NULL
extracts	NULL
by	NULL
incubation	NULL
with	NULL
EIA	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
,	NULL
whereas	NULL
ElA	NULL
treatments	NULL
of	NULL
G	NULL
,	NULL
cell	NULL
extracts	NULL
never	NULL
generated	NULL
detectable	NULL
levels	NULL
of	NULL
A	NULL
'	NULL
.	NULL

One	NULL
interpretation	NULL
of	NULL
these	NULL
results	NULL
is	NULL
that	NULL
the	NULL
form	NULL
of	NULL
E2F	NULL
responsible	NULL
for	NULL
A	NULL
is	NULL
present	NULL
in	NULL
G	NULL
,	NULL
,	NULL
although	NULL
not	NULL
in	NULL
its	NULL
free	NULL
form	NULL
(	NULL
A	NULL
)	NULL
but	NULL
instead	NULL
sequestered	NULL
in	NULL
complex	NULL
X	NULL
(	NULL
see	NULL
above	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
two	NULL
major	NULL
forms	NULL
of	NULL
free	NULL
E2F	NULL
behaved	NULL
differently	NULL
;	NULL
A	NULL
first	NULL
appeared	NULL
3980	NULL
CHITTENDEN	NULL
competit	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Temporal	NULL
order	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
E2F	NULL
activities	NULL
following	NULL
mitogen	NULL
stimulation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Analysis	NULL
at	NULL
0	NULL
h	NULL
(	NULL
unstimulated	NULL
)	NULL
,	NULL
20	NULL
h	NULL
,	NULL
and	NULL
40	NULL
h	NULL
after	NULL
mitogen	NULL
stimulation	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
and	NULL
incubated	NULL
either	NULL
with	NULL
(	NULL
+	NULL
)	NULL
or	NULL
without	NULL
(	NULL
-	NULL
)	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
specific	NULL
oligonucleotide	NULL
competitor	NULL
(	NULL
DHFR	NULL
WT	NULL
)	NULL
.	NULL

Reactions	NULL
were	NULL
then	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Analysis	NULL
at	NULL
0	NULL
h	NULL
(	NULL
unstimulated	NULL
)	NULL
and	NULL
6	NULL
h	NULL
after	NULL
mitogen	NULL
addition	NULL
.	NULL

Extracts	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
indicated	NULL
oligonucleotide	NULL
(	NULL
-	NULL
denotes	NULL
no	NULL
competitor	NULL
added	NULL
)	NULL
.	NULL

EZpro	NULL
and	NULL
DHFR	NULL
WT	NULL
contain	NULL
E2F	NULL
binding	NULL
sites	NULL
.	NULL

BK	NULL
consists	NULL
of	NULL
an	NULL
unrelated	NULL
DNA	NULL
sequence	NULL
.	NULL

shortly	NULL
after	NULL
mitogen	NULL
stimulation	NULL
(	NULL
early	NULL
G	NULL
,	NULL
)	NULL
,	NULL
whereas	NULL
A	NULL
'	NULL
emerged	NULL
at	NULL
the	NULL
onset	NULL
of	NULL
S	NULL
(	NULL
or	NULL
possibly	NULL
late	NULL
G	NULL
,	NULL
)	NULL
.	NULL

Elutriation	NULL
experiments	NULL
yielded	NULL
analogous	NULL
findings	NULL
regarding	NULL
the	NULL
temporal	NULL
regulation	NULL
of	NULL
different	NULL
E2F	NULL
species	NULL
.	NULL

A	NULL
preparation	NULL
of	NULL
mitogen-stimulated	NULL
T	NULL
cells	NULL
(	NULL
43	NULL
h	NULL
poststimula-tion	NULL
)	NULL
,	NULL
was	NULL
fractionated	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
.	NULL

Extracts	NULL
were	NULL
prepared	NULL
from	NULL
G	NULL
,	NULL
-	NULL
and	NULL
S-phase-enriched	NULL
cell	NULL
fractions	NULL
(	NULL
as	NULL
determined	NULL
by	NULL
fluorescence-activated	NULL
cell	NULL
sorting	NULL
[	NULL
FACS	NULL
]	NULL
analysis	NULL
)	NULL
,	NULL
and	NULL
E2ZF	NULL
DNA-binding	NULL
activities	NULL
were	NULL
monitored	NULL
by	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

The	NULL
p107-cyclin	NULL
A	NULL
complex	NULL
(	NULL
C	NULL
)	NULL
appeared	NULL
only	NULL
in	NULL
fractions	NULL
containing	NULL
S-phase	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
fractions	NULL
6	NULL
through	NULL
9	NULL
)	NULL
.	NULL

The	NULL
major	NULL
Rb-E2F	NULL
complex	NULL
(	NULL
B	NULL
)	NULL
,	NULL
while	NULL
present	NULL
in	NULL
G	NULL
,	NULL
(	NULL
seen	NULL
more	NULL
clearly	NULL
on	NULL
longer	NULL
exposures	NULL
)	NULL
,	NULL
persisted	NULL
in	NULL
all	NULL
S-phase	NULL
fractions	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
fractions	NULL
6	NULL
through	NULL
9	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
previous	NULL
findings	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
behavior	NULL
of	NULL
the	NULL
minor	NULL
Rb-EZF	NULL
complex	NULL
,	NULL
Y	NULL
,	NULL
appeared	NULL
to	NULL
parallel	NULL
that	NULL
of	NULL
B	NULL
.	NULL

By	NULL
contrast	NULL
to	NULL
Rb-EZF	NULL
complexes	NULL
,	NULL
X	NULL
was	NULL
restricted	NULL
almost	NULL
completely	NULL
to	NULL
G/G	NULL
,	NULL
-enriched	NULL
fractions	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
fractions	NULL
3	NULL
through	NULL
6	NULL
)	NULL
.	NULL

Z	NULL
could	NULL
be	NULL
detected	NULL
only	NULL
after	NULL
long	NULL
exposures	NULL
,	NULL
and	NULL
it	NULL
was	NULL
not	NULL
possible	NULL
to	NULL
determine	NULL
whether	NULL
its	NULL
abundance	NULL
varied	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Levels	NULL
of	NULL
the	NULL
two	NULL
major	NULL
free	NULL
E2F	NULL
species	NULL
A	NULL
and	NULL
A	NULL
'	NULL
again	NULL
displayed	NULL
differences	NULL
in	NULL
cell	NULL
cycle	NULL
dependency	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

A	NULL
was	NULL
detected	NULL
in	NULL
both	NULL
G	NULL
,	NULL
and	NULL
S	NULL
fractions	NULL
but	NULL
was	NULL
less	NULL
abundant	NULL
in	NULL
G	NULL
,	NULL
.	NULL

A	NULL
'	NULL
was	NULL
nearly	NULL
absent	NULL
in	NULL
early	NULL
G	NULL
,	NULL
fractions	NULL
and	NULL
increased	NULL
substantially	NULL
in	NULL
late	NULL
G	NULL
,	NULL
/early	NULL
S	NULL
phase	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
fractions	NULL
6	NULL
through	NULL
9	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
results	NULL
described	NULL
above	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
showing	NULL
that	NULL
A	NULL
appeared	NULL
shortly	NULL
after	NULL
stimulation	NULL
of	NULL
resting	NULL
T	NULL
cells	NULL
(	NULL
early	NULL
G	NULL
;	NULL
)	NULL
,	NULL
whereas	NULL
A	NULL
'	NULL
was	NULL
not	NULL
detected	NULL
until	NULL
the	NULL
G	NULL
,	NULL
/S	NULL
transition	NULL
.	NULL

It	NULL
was	NULL
not	NULL
possible	NULL
to	NULL
decipher	NULL
the	NULL
kinetics	NULL
of	NULL
A	NULL
``	NULL
,	NULL
given	NULL
its	NULL
relatively	NULL
low	NULL
abundance	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
exposure	NULL
to	NULL
ElA	NULL
.	NULL

UV	NULL
cross-linking	NULL
provides	NULL
additional	NULL
evidence	NULL
for	NULL
biochemically	NULL
distinct	NULL
forms	NULL
of	NULL
E2F	NULL
.	NULL

The	NULL
wide	NULL
variety	NULL
of	NULL
E2F	NULL
activities	NULL
observed	NULL
in	NULL
these	NULL
experiments	NULL
may	NULL
result	NULL
from	NULL
a	NULL
single	NULL
transcription	NULL
factor	NULL
interacting	NULL
with	NULL
multiple	NULL
different	NULL
cellular	NULL
proteins	NULL
.	NULL

The	NULL
diversity	NULL
of	NULL
E2F	NULL
complexes	NULL
may	NULL
also	NULL
result	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bou	NULL
.	NULL

Mbt	NULL
t-	NULL
AM	NULL
G2/M	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

EMSA	NULL
analysis	NULL
of	NULL
elutriated	NULL
T	NULL
cells	NULL
.	NULL

Stimulated	NULL
T	NULL
cells	NULL
(	NULL
43	NULL
h	NULL
after	NULL
mitogen	NULL
addition	NULL
)	NULL
were	NULL
fractionated	NULL
by	NULL
centrifugal	NULL
elutriation	NULL
,	NULL
and	NULL
fractions	NULL
that	NULL
were	NULL
enriched	NULL
for	NULL
G	NULL
,	NULL
-	NULL
and	NULL
S-phase	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Fraction	NULL
C	NULL
was	NULL
prepared	NULL
from	NULL
the	NULL
asynchronous	NULL
culture	NULL
prior	NULL
to	NULL
elutriation	NULL
.	NULL

The	NULL
gel	NULL
mobilities	NULL
of	NULL
the	NULL
various	NULL
E2F	NULL
species	NULL
are	NULL
indicated	NULL
.	NULL

The	NULL
cell	NULL
cycle	NULL
profile	NULL
of	NULL
the	NULL
fractions	NULL
was	NULL
determined	NULL
by	NULL
FACS	NULL
analysis	NULL
of	NULL
cellular	NULL
DNA	NULL
content	NULL
and	NULL
is	NULL
listed	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

nd	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

from	NULL
the	NULL
presence	NULL
of	NULL
multiple	NULL
E2F	NULL
species	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
a	NULL
family	NULL
of	NULL
related	NULL
transcription	NULL
factors	NULL
with	NULL
E2F	NULL
DNA-binding	NULL
activi-ty	NULL
)	NULL
,	NULL
at	NULL
least	NULL
some	NULL
of	NULL
which	NULL
form	NULL
complexes	NULL
with	NULL
a	NULL
variety	NULL
of	NULL
cellular	NULL
proteins	NULL
.	NULL

As	NULL
one	NULL
approach	NULL
to	NULL
investigating	NULL
whether	NULL
different	NULL
E2F	NULL
species	NULL
are	NULL
present	NULL
in	NULL
various	NULL
E2F	NULL
complexes	NULL
,	NULL
we	NULL
performed	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
.	NULL

Gel	NULL
shift	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
a	NULL
BuDR-substituted	NULL
Â°P-labeled	NULL
EZF	NULL
binding	NULL
site	NULL
probe	NULL
.	NULL

Following	NULL
native	NULL
gel	NULL
electrophoresis	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
irradiated	NULL
with	NULL
UV	NULL
light	NULL
in	NULL
order	NULL
to	NULL
covalently	NULL
cross-link	NULL
the	NULL
probe	NULL
to	NULL
the	NULL
DNA-binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

Individual	NULL
bands	NULL
corresponding	NULL
to	NULL
E2F	NULL
complexes	NULL
A	NULL
,	NULL
B	NULL
,	NULL
C	NULL
,	NULL
and	NULL
X	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
gel	NULL
,	NULL
and	NULL
the	NULL
Â°Â°P	NULL
photoaffinity-labeled	NULL
protein	NULL
within	NULL
these	NULL
bands	NULL
was	NULL
fractionated	NULL
by	NULL
SDS-gel	NULL
electrophoresis	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
a	NULL
nonspecific	NULL
band	NULL
(	NULL
lane	NULL
NS	NULL
)	NULL
was	NULL
also	NULL
excised	NULL
and	NULL
analyzed	NULL
in	NULL
parallel	NULL
.	NULL

Cross-linking	NULL
experiments	NULL
with	NULL
the	NULL
minor	NULL
E2F	NULL
species	NULL
(	NULL
Y	NULL
,	NULL
Z	NULL
,	NULL
and	NULL
A	NULL
``	NULL
)	NULL
proved	NULL
difficult	NULL
because	NULL
of	NULL
the	NULL
low	NULL
abundance	NULL
of	NULL
these	NULL
species	NULL
and	NULL
were	NULL
not	NULL
informa-tive	NULL
.	NULL

A	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
with	NULL
an	NULL
approximate	NULL
molecular	NULL
mass	NULL
of	NULL
56	NULL
kDa	NULL
(	NULL
relative	NULL
to	NULL
prestained	NULL
markers	NULL
)	NULL
was	NULL
cross-linked	NULL
in	NULL
each	NULL
E2F	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

8A	NULL
)	NULL
,	NULL
which	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
on	NULL
the	NULL
molecular	NULL
weight	NULL
of	NULL
E2F	NULL
(	NULL
43	NULL
)	NULL
.	NULL

The	NULL
56-kDa	NULL
band	NULL
in	NULL
lane	NULL
B	NULL
was	NULL
faint	NULL
in	NULL
the	NULL
exposure	NULL
shown	NULL
.	NULL

Proteins	NULL
with	NULL
small	NULL
differences	NULL
in	NULL
molecular	NULL
weight	NULL
might	NULL
not	NULL
be	NULL
resolved	NULL
on	NULL
this	NULL
gel	NULL
.	NULL

However	NULL
,	NULL
even	NULL
at	NULL
this	NULL
resolution	NULL
,	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
two	NULL
proteins	NULL
(	NULL
approximately	NULL
56	NULL
and	NULL
60	NULL
kDa	NULL
)	NULL
emerged	NULL
from	NULL
the	NULL
cross-linking	NULL
of	NULL
C	NULL
,	NULL
the	NULL
p107-cyclin	NULL
A-E2F	NULL
complex	NULL
.	NULL

The	NULL
60-kDa	NULL
protein	NULL
was	NULL
specific	NULL
to	NULL
complex	NULL
C	NULL
and	NULL
was	NULL
not	NULL
cross-linked	NULL
in	NULL
any	NULL
of	NULL
the	NULL
other	NULL
E2F	NULL
complexes	NULL
examined	NULL
,	NULL
whereas	NULL
the	NULL
faster-migrating	NULL
band	NULL
was	NULL
indistinguishable	NULL
by	NULL
gel	NULL
migration	NULL
from	NULL
that	NULL
emerging	NULL
from	NULL
complexes	NULL
X	NULL
,	NULL
A	NULL
,	NULL
and	NULL
B	NULL
.	NULL

Identical	NULL
results	NULL
were	NULL
obtained	NULL
upon	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
A	NULL
T	NULL
cells	NULL
B	NULL
U937	NULL
crosslinked	NULL
E2F	NULL
complex	NULL
NS	NULL
X	NULL
A	NULL
B	NULL
C	NULL
A.B	NULL
.	NULL

:	NULL
C	NULL
180	NULL
116	NULL
84	NULL
49	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

UV	NULL
cross-linking	NULL
analysis	NULL
of	NULL
E2F	NULL
complexes	NULL
.	NULL

Gel	NULL
shift	NULL
experiments	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
a	NULL
*Â°P-labeled	NULL
,	NULL
BUdR-substituted	NULL
E2F	NULL
binding	NULL
site	NULL
probe	NULL
,	NULL
with	NULL
extracts	NULL
prepared	NULL
from	NULL
either	NULL
T	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
or	NULL
U937	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Following	NULL
native	NULL
gel	NULL
electrophoresis	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
irradiated	NULL
with	NULL
UV	NULL
light	NULL
,	NULL
and	NULL
the	NULL
indicated	NULL
E2F	NULL
complexes	NULL
(	NULL
X	NULL
,	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C	NULL
)	NULL
were	NULL
excised	NULL
from	NULL
the	NULL
gel	NULL
.	NULL

A	NULL
nonspecific	NULL
band	NULL
(	NULL
NS	NULL
)	NULL
was	NULL
also	NULL
excised	NULL
.	NULL

Labeled	NULL
proteins	NULL
within	NULL
the	NULL
excised	NULL
bands	NULL
were	NULL
then	NULL
separated	NULL
by	NULL
electrophoresis	NULL
in	NULL
an	NULL
SDS-8	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
gel	NULL
mobilities	NULL
of	NULL
prestained	NULL
protein	NULL
molecular	NULL
weight	NULL
markers	NULL
are	NULL
indicated	NULL
in	NULL
kilodaltons	NULL
.	NULL

analysis	NULL
of	NULL
E2F	NULL
complexes	NULL
in	NULL
the	NULL
human	NULL
promonocytic	NULL
leukemia	NULL
cell	NULL
line	NULL
U937	NULL
.	NULL

Complex	NULL
C	NULL
in	NULL
U937	NULL
cells	NULL
yielded	NULL
two	NULL
cross-linked	NULL
proteins	NULL
with	NULL
approximate	NULL
molecular	NULL
masses	NULL
of	NULL
56	NULL
and	NULL
60	NULL
kDa	NULL
(	NULL
Fig	NULL
.	NULL

8B	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
the	NULL
S-phase	NULL
p107-E2F	NULL
complex	NULL
contains	NULL
an	NULL
E2F	NULL
DNA-binding	NULL
protein	NULL
of	NULL
greater	NULL
molecular	NULL
weight	NULL
than	NULL
those	NULL
found	NULL
in	NULL
other	NULL
E2F	NULL
complexes	NULL
and	NULL
imply	NULL
that	NULL
p107	NULL
interacts	NULL
with	NULL
at	NULL
least	NULL
two	NULL
different	NULL
E2F	NULL
species	NULL
.	NULL

The	NULL
60-kDa	NULL
protein	NULL
might	NULL
be	NULL
an	NULL
E2F	NULL
species	NULL
of	NULL
different	NULL
primary	NULL
sequence	NULL
,	NULL
the	NULL
same	NULL
primary	NULL
but	NULL
different	NULL
covalent	NULL
modification	NULL
structure	NULL
,	NULL
or	NULL
both	NULL
.	NULL

DISCUSSION	NULL
An	NULL
increasingly	NULL
complex	NULL
picture	NULL
of	NULL
E2F	NULL
and	NULL
its	NULL
cell	NULL
cycle	NULL
regulation	NULL
has	NULL
emerged	NULL
from	NULL
the	NULL
analysis	NULL
of	NULL
E2F	NULL
in	NULL
primary	NULL
human	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
wish	NULL
to	NULL
summarize	NULL
here	NULL
the	NULL
main	NULL
findings	NULL
obtained	NULL
in	NULL
this	NULL
study	NULL
.	NULL

First	NULL
,	NULL
several	NULL
new	NULL
E2F	NULL
DNA-binding	NULL
activities	NULL
were	NULL
identified	NULL
and	NULL
characterized	NULL
.	NULL

These	NULL
include	NULL
an	NULL
additional	NULL
Rb-EZF	NULL
complex	NULL
(	NULL
Y	NULL
)	NULL
distinct	NULL
from	NULL
the	NULL
previously	NULL
identified	NULL
complex	NULL
(	NULL
B	NULL
)	NULL
,	NULL
a	NULL
novel	NULL
form	NULL
of	NULL
free	NULL
E2F	NULL
(	NULL
A	NULL
``	NULL
)	NULL
,	NULL
a	NULL
more	NULL
slowly	NULL
migrating	NULL
species	NULL
of	NULL
completely	NULL
unknown	NULL
composition	NULL
(	NULL
Z	NULL
)	NULL
,	NULL
and	NULL
an	NULL
E2F	NULL
complex	NULL
(	NULL
X	NULL
)	NULL
restricted	NULL
to	NULL
Gy/G	NULL
,	NULL
that	NULL
appears	NULL
to	NULL
involve	NULL
an	NULL
interaction	NULL
with	NULL
an	NULL
El1A-binding	NULL
protein	NULL
possibly	NULL
different	NULL
from	NULL
Rb	NULL
or	NULL
p107	NULL
(	NULL
discussed	NULL
below	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
the	NULL
results	NULL
provide	NULL
evidence	NULL
for	NULL
significant	NULL
biochemical	NULL
diversity	NULL
in	NULL
the	NULL
DNA-binding	NULL
activities	NULL
that	NULL
have	NULL
collectively	NULL
been	NULL
termed	NULL
E2F	NULL
.	NULL

Three	NULL
forms	NULL
of	NULL
free	NULL
E2F	NULL
(	NULL
A	NULL
,	NULL
A	NULL
'	NULL
,	NULL
and	NULL
A	NULL
``	NULL
)	NULL
with	NULL
distinctly	NULL
different	NULL
gel	NULL
mobilities	NULL
were	NULL
resolved	NULL
in	NULL
EMSAs	NULL
,	NULL
and	NULL
at	NULL
least	NULL
two	NULL
proteins	NULL
of	NULL
different	NULL
molecular	NULL
weights	NULL
were	NULL
photoaffinity	NULL
labeled	NULL
in	NULL
UV	NULL
cross-linking	NULL
experiments	NULL
.	NULL

Third	NULL
,	NULL
experiments	NULL
with	NULL
synchronized	NULL
cells	NULL
demonstrated	NULL
that	NULL
the	NULL
two	NULL
major	NULL
free	NULL
E2F	NULL
species	NULL
(	NULL
A	NULL
and	NULL
A	NULL
'	NULL
)	NULL
displayed	NULL
distinct	NULL
behavior	NULL
within	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

These	NULL
observations	NULL
raise	NULL
the	NULL
possibility	NULL
(	NULL
see	NULL
below	NULL
)	NULL
that	NULL
different	NULL
species	NULL
of	NULL
free	NULL
E2F	NULL
perform	NULL
different	NULL
biological	NULL
functions	NULL
.	NULL

NOVEL	NULL
E2F	NULL
SPECIES	NULL
IN	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
3981	NULL
Of	NULL
the	NULL
additional	NULL
E2F	NULL
complexes	NULL
described	NULL
in	NULL
this	NULL
report	NULL
,	NULL
X	NULL
is	NULL
of	NULL
particular	NULL
interest	NULL
.	NULL

X	NULL
is	NULL
by	NULL
far	NULL
the	NULL
most	NULL
abundant	NULL
G/G	NULL
,	NULL
E2F	NULL
DNA-binding	NULL
activity	NULL
.	NULL

The	NULL
temporal	NULL
pattern	NULL
of	NULL
X	NULL
is	NULL
tightly	NULL
restricted	NULL
to	NULL
G	NULL
,	NULL
and	NULL
G	NULL
,	NULL
,	NULL
unlike	NULL
the	NULL
case	NULL
for	NULL
Rb-E2F	NULL
complexes	NULL
,	NULL
which	NULL
are	NULL
also	NULL
found	NULL
in	NULL
S	NULL
phase	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
the	NULL
behavior	NULL
of	NULL
X	NULL
more	NULL
closely	NULL
fits	NULL
what	NULL
might	NULL
be	NULL
predicted	NULL
for	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
E2F	NULL
function	NULL
,	NULL
since	NULL
cells	NULL
must	NULL
prevent	NULL
E2F	NULL
from	NULL
activating	NULL
growth-responsive	NULL
genes	NULL
at	NULL
inappropriate	NULL
times	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
in	NULL
G	NULL
,	NULL
)	NULL
.	NULL

The	NULL
ElA-binding	NULL
protein	NULL
that	NULL
is	NULL
a	NULL
component	NULL
of	NULL
X	NULL
may	NULL
function	NULL
to	NULL
sequester	NULL
E2F	NULL
and	NULL
prevent	NULL
its	NULL
function	NULL
as	NULL
a	NULL
transcriptional	NULL
activation	NULL
.	NULL

Alterna-tively	NULL
,	NULL
since	NULL
X	NULL
binds	NULL
E2F	NULL
sites	NULL
,	NULL
X	NULL
may	NULL
actively	NULL
function	NULL
as	NULL
a	NULL
repressor	NULL
by	NULL
binding	NULL
to	NULL
E2F-responsive	NULL
promoters	NULL
.	NULL

Such	NULL
a	NULL
function	NULL
has	NULL
already	NULL
been	NULL
postulated	NULL
for	NULL
Rb-EZF	NULL
complexes	NULL
(	NULL
41	NULL
)	NULL
.	NULL

If	NULL
so	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
X	NULL
represents	NULL
an	NULL
important	NULL
target	NULL
for	NULL
ElA	NULL
in	NULL
naturally	NULL
occurring	NULL
adenovirus	NULL
infections	NULL
of	NULL
resting	NULL
cells	NULL
.	NULL

What	NULL
is	NULL
the	NULL
composition	NULL
of	NULL
X	NULL
?	NULL

The	NULL
results	NULL
presented	NULL
here	NULL
suggest	NULL
that	NULL
one	NULL
component	NULL
of	NULL
X	NULL
is	NULL
an	NULL
E1A-binding	NULL
protein	NULL
other	NULL
than	NULL
Rb	NULL
or	NULL
p107	NULL
.	NULL

Antibodies	NULL
to	NULL
Rb	NULL
and	NULL
p107	NULL
which	NULL
successfully	NULL
supershifted	NULL
Rb-E2F	NULL
and	NULL
p107-E2F	NULL
complexes	NULL
failed	NULL
to	NULL
alter	NULL
X	NULL
,	NULL
yet	NULL
ElA	NULL
dissociation	NULL
of	NULL
X	NULL
required	NULL
ElA	NULL
conserved	NULL
region	NULL
2	NULL
.	NULL

At	NULL
least	NULL
three	NULL
cellular	NULL
proteins	NULL
in	NULL
addition	NULL
to	NULL
Rb	NULL
and	NULL
p107	NULL
bind	NULL
ElA	NULL
with	NULL
a	NULL
requirement	NULL
for	NULL
this	NULL
sequence	NULL
:	NULL
p80	NULL
,	NULL
p90	NULL
,	NULL
and	NULL
p130	NULL
(	NULL
11	NULL
,	NULL
42	NULL
)	NULL
.	NULL

The	NULL
gel	NULL
mobility	NULL
of	NULL
X	NULL
,	NULL
migrating	NULL
slightly	NULL
more	NULL
slowly	NULL
than	NULL
the	NULL
major	NULL
Rb-E2F	NULL
complex	NULL
,	NULL
makes	NULL
p130	NULL
an	NULL
attractive	NULL
candidate	NULL
.	NULL

However	NULL
,	NULL
it	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
a	NULL
G	NULL
;	NULL
-restricted	NULL
E2F	NULL
complex	NULL
detected	NULL
in	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
reacts	NULL
with	NULL
a	NULL
polyclonal	NULL
p107	NULL
antiserum	NULL
(	NULL
cited	NULL
in	NULL
reference	NULL
30	NULL
as	NULL
J.	NULL
K.	NULL
Schwarz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
unpublished	NULL
data	NULL
[	NULL
36a	NULL
)	NULL
)	NULL
.	NULL

A	NULL
current	NULL
question	NULL
is	NULL
whether	NULL
it	NULL
is	NULL
the	NULL
murine	NULL
equivalent	NULL
of	NULL
X	NULL
.	NULL

Presently	NULL
,	NULL
our	NULL
conclusions	NULL
are	NULL
limited	NULL
to	NULL
stating	NULL
that	NULL
the	NULL
p107	NULL
antibodies	NULL
used	NULL
in	NULL
our	NULL
study	NULL
failed	NULL
to	NULL
react	NULL
with	NULL
X	NULL
,	NULL
although	NULL
they	NULL
did	NULL
supershift	NULL
the	NULL
S-phase	NULL
plQ07-cyclin	NULL
A-E2F	NULL
complex	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
X	NULL
was	NULL
largely	NULL
absent	NULL
from	NULL
many	NULL
transformed	NULL
cell	NULL
lines	NULL
tested	NULL
to	NULL
date	NULL
,	NULL
including	NULL
U937	NULL
,	NULL
Rb27	NULL
,	NULL
U2OS	NULL
,	NULL
SAOS2	NULL
,	NULL
and	NULL
HeLa	NULL
(	NULL
reference	NULL
38	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
failure	NULL
to	NULL
detect	NULL
X	NULL
may	NULL
not	NULL
simply	NULL
be	NULL
due	NULL
to	NULL
insufficient	NULL
G	NULL
,	NULL
cells	NULL
in	NULL
transformed	NULL
cell	NULL
cultures	NULL
,	NULL
since	NULL
X	NULL
was	NULL
not	NULL
detected	NULL
even	NULL
in	NULL
G	NULL
,	NULL
-enriched	NULL
U937	NULL
cell	NULL
fractions	NULL
following	NULL
elutriation	NULL
(	NULL
38	NULL
)	NULL
.	NULL

X	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
specific	NULL
to	NULL
primary	NULL
T	NULL
cells	NULL
,	NULL
since	NULL
we	NULL
have	NULL
detected	NULL
a	NULL
complex	NULL
with	NULL
electrophoretic	NULL
mobility	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
X	NULL
in	NULL
the	NULL
non-transformed	NULL
diploid	NULL
human	NULL
fibroblast	NULL
line	NULL
MRC-5	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
Pagano	NULL
et	NULL
al	NULL
.	NULL

(	NULL
32	NULL
)	NULL
detected	NULL
a	NULL
Gy/G	NULL
;	NULL
-specific	NULL
complex	NULL
in	NULL
primary	NULL
human	NULL
fibroblasts	NULL
with	NULL
a	NULL
similar	NULL
gel	NULL
mobility	NULL
.	NULL

An	NULL
interesting	NULL
possibility	NULL
is	NULL
that	NULL
X	NULL
is	NULL
frequently	NULL
lost	NULL
or	NULL
disrupted	NULL
in	NULL
transformed	NULL
cells	NULL
.	NULL

If	NULL
X	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
E2F	NULL
function	NULL
,	NULL
perhaps	NULL
its	NULL
loss	NULL
contributes	NULL
to	NULL
deregulation	NULL
of	NULL
growth-responsive	NULL
promoters	NULL
and	NULL
the	NULL
transformation	NULL
process	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
free	NULL
E2F	NULL
is	NULL
the	NULL
form	NULL
active	NULL
in	NULL
stimulating	NULL
transcription	NULL
(	NULL
1	NULL
)	NULL
.	NULL

As	NULL
demonstrated	NULL
in	NULL
this	NULL
work	NULL
,	NULL
there	NULL
are	NULL
at	NULL
least	NULL
three	NULL
forms	NULL
of	NULL
free	NULL
E2F	NULL
that	NULL
can	NULL
be	NULL
resolved	NULL
in	NULL
EMSAs	NULL
(	NULL
A	NULL
,	NULL
A	NULL
'	NULL
,	NULL
and	NULL
A	NULL
``	NULL
)	NULL
.	NULL

If	NULL
free	NULL
E2F	NULL
is	NULL
the	NULL
form	NULL
responsible	NULL
for	NULL
activation	NULL
of	NULL
cellular	NULL
promoters	NULL
(	NULL
a	NULL
possibility	NULL
that	NULL
remains	NULL
to	NULL
be	NULL
proven	NULL
)	NULL
,	NULL
it	NULL
is	NULL
of	NULL
particular	NULL
interest	NULL
to	NULL
note	NULL
the	NULL
different	NULL
cell	NULL
cycle	NULL
kinetics	NULL
of	NULL
the	NULL
two	NULL
predominant	NULL
species	NULL
of	NULL
free	NULL
E2F	NULL
.	NULL

As	NULL
might	NULL
be	NULL
expected	NULL
,	NULL
no	NULL
free	NULL
E2F	NULL
was	NULL
detected	NULL
in	NULL
unstimulated	NULL
T	NULL
cells	NULL
(	NULL
G	NULL
,	NULL
,	NULL
)	NULL
.	NULL

Shortly	NULL
after	NULL
mitogen	NULL
stimulation	NULL
(	NULL
between	NULL
0	NULL
and	NULL
6	NULL
h	NULL
)	NULL
,	NULL
free	NULL
E2F	NULL
species	NULL
A	NULL
appeared	NULL
,	NULL
and	NULL
it	NULL
was	NULL
not	NULL
until	NULL
the	NULL
G	NULL
,	NULL
/S	NULL
transition	NULL
(	NULL
24	NULL
to	NULL
36	NULL
h	NULL
poststimula-tion	NULL
)	NULL
that	NULL
A	NULL
'	NULL
was	NULL
first	NULL
detected	NULL
.	NULL

This	NULL
temporal	NULL
regulation	NULL
suggests	NULL
a	NULL
scenario	NULL
wherein	NULL
A	NULL
activates	NULL
immediate-early	NULL
E2F-responsive	NULL
promoters	NULL
such	NULL
as	NULL
the	NULL
c-myc	NULL
promoter	NULL
,	NULL
3982	NULL
CHITTENDEN	NULL
whereas	NULL
A	NULL
'	NULL
functions	NULL
primarily	NULL
at	NULL
promoters	NULL
activated	NULL
at	NULL
G	NULL
,	NULL
/S	NULL
,	NULL
such	NULL
as	NULL
the	NULL
DHFR	NULL
promoter	NULL
.	NULL

In	NULL
elutriated	NULL
cells	NULL
,	NULL
A	NULL
'	NULL
was	NULL
most	NULL
abundant	NULL
in	NULL
late	NULL
G	NULL
,	NULL
/early	NULL
S-phase	NULL
fractions	NULL
,	NULL
again	NULL
consistent	NULL
with	NULL
a	NULL
role	NULL
for	NULL
A	NULL
'	NULL
in	NULL
activating	NULL
genes	NULL
at	NULL
the	NULL
G	NULL
,	NULL
/S	NULL
transition	NULL
.	NULL

Several	NULL
explanations	NULL
could	NULL
account	NULL
for	NULL
the	NULL
observed	NULL
diversity	NULL
of	NULL
free	NULL
E2F	NULL
species	NULL
.	NULL

It	NULL
seems	NULL
unlikely	NULL
that	NULL
the	NULL
different	NULL
forms	NULL
of	NULL
free	NULL
E2F	NULL
described	NULL
here	NULL
simply	NULL
reflect	NULL
in	NULL
vitro	NULL
proteolysis	NULL
of	NULL
a	NULL
single	NULL
progenitor	NULL
species	NULL
.	NULL

The	NULL
relative	NULL
levels	NULL
of	NULL
A	NULL
and	NULL
A	NULL
'	NULL
do	NULL
not	NULL
vary	NULL
following	NULL
repeated	NULL
freeze-thawings	NULL
of	NULL
a	NULL
cell	NULL
extract	NULL
and	NULL
appeared	NULL
and	NULL
disappeared	NULL
in	NULL
a	NULL
reproducible	NULL
cell	NULL
cycle-dependent	NULL
manner	NULL
.	NULL

Furthermore	NULL
,	NULL
since	NULL
A	NULL
and	NULL
A	NULL
'	NULL
exhibit	NULL
different	NULL
cell	NULL
cycle	NULL
behaviors	NULL
,	NULL
if	NULL
proteolysis	NULL
accounted	NULL
for	NULL
their	NULL
existence	NULL
,	NULL
it	NULL
too	NULL
would	NULL
have	NULL
to	NULL
be	NULL
cell	NULL
cycle	NULL
dependent	NULL
.	NULL

More	NULL
to	NULL
the	NULL
point	NULL
,	NULL
if	NULL
A	NULL
'	NULL
and	NULL
A	NULL
``	NULL
are	NULL
indeed	NULL
degradation	NULL
products	NULL
,	NULL
they	NULL
have	NULL
been	NULL
proteo-lyzed	NULL
in	NULL
such	NULL
a	NULL
way	NULL
as	NULL
to	NULL
retain	NULL
DNA-binding	NULL
activity	NULL
and	NULL
to	NULL
have	NULL
the	NULL
potential	NULL
to	NULL
associate	NULL
with	NULL
E4	NULL
and	NULL
Rb	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
other	NULL
posttranslational	NULL
modifications	NULL
such	NULL
as	NULL
dimeriza-tion	NULL
or	NULL
phosphorylation	NULL
account	NULL
for	NULL
some	NULL
heterogeneity	NULL
of	NULL
E2F	NULL
activities	NULL
.	NULL

A	NULL
'	NULL
,	NULL
for	NULL
example	NULL
,	NULL
could	NULL
be	NULL
generated	NULL
by	NULL
a	NULL
posttranslational	NULL
modification	NULL
of	NULL
A	NULL
,	NULL
such	NULL
as	NULL
phosphoryla-tion	NULL
,	NULL
occurring	NULL
in	NULL
late	NULL
G	NULL
,	NULL
/early	NULL
S.	NULL
UV	NULL
cross-linking	NULL
of	NULL
E2F	NULL
complex	NULL
C	NULL
yielded	NULL
two	NULL
proteins	NULL
of	NULL
56	NULL
and	NULL
60	NULL
kDa	NULL
.	NULL

The	NULL
larger	NULL
of	NULL
these	NULL
could	NULL
be	NULL
a	NULL
phosphorylated	NULL
form	NULL
of	NULL
the	NULL
smaller	NULL
,	NULL
and	NULL
if	NULL
so	NULL
,	NULL
E2F	NULL
could	NULL
conceivably	NULL
be	NULL
a	NULL
substrate	NULL
of	NULL
the	NULL
cyclin	NULL
A/cdk2	NULL
kinase	NULL
present	NULL
in	NULL
C.	NULL
An	NULL
alternative	NULL
,	NULL
but	NULL
not	NULL
mutually	NULL
exclusive	NULL
,	NULL
possibility	NULL
is	NULL
that	NULL
heterogeneity	NULL
of	NULL
E2F	NULL
activities	NULL
may	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
family	NULL
of	NULL
related	NULL
E2F	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

If	NULL
so	NULL
,	NULL
the	NULL
different	NULL
free	NULL
E2F	NULL
species	NULL
(	NULL
A	NULL
,	NULL
A	NULL
'	NULL
,	NULL
and	NULL
A	NULL
``	NULL
)	NULL
may	NULL
be	NULL
the	NULL
products	NULL
of	NULL
several	NULL
related	NULL
genes	NULL
.	NULL

There	NULL
is	NULL
ample	NULL
precedence	NULL
for	NULL
families	NULL
of	NULL
related	NULL
transcription	NULL
factors	NULL
all	NULL
recognizing	NULL
similar	NULL
DNA	NULL
sequences	NULL
(	NULL
18	NULL
)	NULL
.	NULL

One	NULL
cDNA	NULL
for	NULL
E2F	NULL
(	NULL
designated	NULL
E2F-1	NULL
)	NULL
has	NULL
been	NULL
cloned	NULL
(	NULL
13	NULL
,	NULL
19	NULL
,	NULL
37	NULL
)	NULL
.	NULL

However	NULL
,	NULL
additional	NULL
clones	NULL
with	NULL
related	NULL
structure	NULL
have	NULL
recently	NULL
been	NULL
isolated	NULL
(	NULL
22a	NULL
)	NULL
.	NULL

A	NULL
polyclonal	NULL
antiserum	NULL
raised	NULL
against	NULL
E2F-1	NULL
reacted	NULL
with	NULL
A	NULL
'	NULL
but	NULL
did	NULL
not	NULL
perturb	NULL
either	NULL
A	NULL
or	NULL
A	NULL
``	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
providing	NULL
evidence	NULL
that	NULL
A	NULL
and	NULL
A	NULL
``	NULL
are	NULL
immunologically	NULL
distinct	NULL
from	NULL
A	NULL
'	NULL
and	NULL
thus	NULL
may	NULL
be	NULL
gene	NULL
products	NULL
different	NULL
from	NULL
E2F-1	NULL
.	NULL

The	NULL
conclusion	NULL
that	NULL
E2F-1	NULL
is	NULL
solely	NULL
a	NULL
component	NULL
of	NULL
A	NULL
'	NULL
is	NULL
consistent	NULL
with	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
analysis	NULL
of	NULL
E2F-1	NULL
gene	NULL
expression	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
EZF-1	NULL
mRNA	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
unstimulated	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
temporal	NULL
appearance	NULL
of	NULL
the	NULL
EZF-1	NULL
message	NULL
following	NULL
mitogen	NULL
stimulation	NULL
correlates	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
A	NULL
'	NULL
by	NULL
EMSA	NULL
analysis	NULL
.	NULL

If	NULL
these	NULL
various	NULL
species	NULL
of	NULL
free	NULL
E2F	NULL
are	NULL
different	NULL
members	NULL
of	NULL
an	NULL
E2F	NULL
gene	NULL
family	NULL
,	NULL
the	NULL
data	NULL
presented	NULL
here	NULL
suggest	NULL
that	NULL
they	NULL
may	NULL
,	NULL
in	NULL
part	NULL
,	NULL
function	NULL
at	NULL
different	NULL
points	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
one	NULL
could	NULL
speculate	NULL
that	NULL
different	NULL
E2F	NULL
family	NULL
members	NULL
selectively	NULL
interact	NULL
with	NULL
different	NULL
cellular	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
Rb	NULL
,	NULL
p107	NULL
,	NULL
and	NULL
perhaps	NULL
other	NULL
nuclear	NULL
pocket	NULL
proteins	NULL
.	NULL

A	NULL
'	NULL
,	NULL
for	NULL
example	NULL
,	NULL
does	NULL
not	NULL
seem	NULL
to	NULL
be	NULL
a	NULL
component	NULL
of	NULL
X	NULL
.	NULL

The	NULL
60-kDa	NULL
protein	NULL
identified	NULL
by	NULL
UV	NULL
cross-linking	NULL
appeared	NULL
specifically	NULL
in	NULL
the	NULL
p107	NULL
complex	NULL
,	NULL
implying	NULL
that	NULL
this	NULL
form	NULL
may	NULL
interact	NULL
exclusively	NULL
with	NULL
p107	NULL
,	NULL
not	NULL
with	NULL
Rb	NULL
or	NULL
the	NULL
E2F-binding	NULL
protein	NULL
in	NULL
complex	NULL
X	NULL
.	NULL

A	NULL
major	NULL
challenge	NULL
for	NULL
the	NULL
future	NULL
will	NULL
be	NULL
to	NULL
determine	NULL
in	NULL
detail	NULL
the	NULL
nature	NULL
of	NULL
the	NULL
E2F	NULL
gene	NULL
product	NULL
(	NULL
s	NULL
)	NULL
present	NULL
in	NULL
the	NULL
various	NULL
complexes	NULL
and	NULL
when	NULL
,	NULL
where	NULL
,	NULL
and	NULL
how	NULL
these	NULL
complexes	NULL
operate	NULL
during	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Nick	NULL
Dyson	NULL
and	NULL
Emma	NULL
Lees	NULL
for	NULL
providing	NULL
p107	NULL
and	NULL
cyclin	NULL
E	NULL
monoclonal	NULL
antibodies	NULL
prior	NULL
to	NULL
publication	NULL
,	NULL
Mark	NULL
Ewen	NULL
for	NULL
supplying	NULL
polyclonal	NULL
p107	NULL
antisera	NULL
,	NULL
and	NULL
Willy	NULL
Krek	NULL
for	NULL
providing	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

affinity-purified	NULL
E2F-1	NULL
antiserum	NULL
.	NULL

We	NULL
thank	NULL
Yun	NULL
Wang	NULL
and	NULL
Candace	NULL
Shaw	NULL
for	NULL
technical	NULL
assistance	NULL
in	NULL
preparing	NULL
T	NULL
cells	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
the	NULL
members	NULL
of	NULL
our	NULL
research	NULL
group	NULL
for	NULL
many	NULL
useful	NULL
suggestions	NULL
and	NULL
criticisms	NULL
.	NULL

We	NULL
thank	NULL
Richard	NULL
Eckner	NULL
and	NULL
Willy	NULL
Krek	NULL
for	NULL
helpful	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

T.C	NULL
.	NULL

was	NULL
supported	NULL
by	NULL
a	NULL
postdoctoral	NULL
fellowship	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Bagchi	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
Raychaudhuri	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1990	NULL
.	NULL

Adenovirus	NULL
E1A	NULL
can	NULL
dissociate	NULL
heteromeric	NULL
complexes	NULL
involving	NULL
the	NULL
EZF	NULL
transcription	NULL
factor	NULL
:	NULL
a	NULL
novel	NULL
mechanism	NULL
for	NULL
ElA	NULL
trans-activation	NULL
.	NULL

Cell	NULL
62:659-669	NULL
.	NULL

2	NULL
.	NULL

Bagchi	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
Weinmann	NULL
,	NULL
and	NULL
P.	NULL
Raychaudburi	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
retinoblastoma	NULL
protein	NULL
copurifies	NULL
with	NULL
E2F-I	NULL
,	NULL
an	NULL
ElA-regulated	NULL
inhibitor	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
E2F	NULL
.	NULL

Cell	NULL
65:1063-1072	NULL
.	NULL

3	NULL
.	NULL

Bandara	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
and	NULL
N.	NULL
B	NULL
.	NULL

La	NULL
Thangue	NULL
.	NULL

1991	NULL
.	NULL

Adenovirus	NULL
ElA	NULL
prevents	NULL
the	NULL
retinoblastoma	NULL
gene	NULL
product	NULL
from	NULL
complexing	NULL
with	NULL
a	NULL
cellular	NULL
transcription	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
351:494-497	NULL
.	NULL

4	NULL
.	NULL

Blake	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Azizkhan	NULL
.	NULL

1989	NULL
.	NULL

Transcription	NULL
factor	NULL
E2F	NULL
is	NULL
required	NULL
for	NULL
efficient	NULL
expression	NULL
of	NULL
the	NULL
hamster	NULL
dihydrofolate	NULL
reductase	NULL
gene	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:4994-5002	NULL
.	NULL

5	NULL
.	NULL

Cao	NULL
,	NULL
L.	NULL
,	NULL
B.	NULL
Faha	NULL
,	NULL
M.	NULL
Dembski	NULL
,	NULL
L.-H.	NULL
Tsai	NULL
,	NULL
E.	NULL
Harlow	NULL
,	NULL
and	NULL
N.	NULL
Dyson	NULL
.	NULL

1992	NULL
.	NULL

Independent	NULL
binding	NULL
of	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
and	NULL
p107	NULL
to	NULL
the	NULL
transcription	NULL
factor	NULL
E2F	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
355:176-179	NULL
.	NULL

6	NULL
.	NULL

Chellappan	NULL
,	NULL
S.	NULL
P.	NULL
,	NULL
S.	NULL
Hiebert	NULL
,	NULL
M.	NULL
Mudryj	NULL
,	NULL
J.	NULL
M.	NULL
Horowitz	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
E2F	NULL
transcription	NULL
factor	NULL
is	NULL
a	NULL
cellular	NULL
target	NULL
for	NULL
the	NULL
Rb	NULL
protein	NULL
.	NULL

Cell	NULL
6Â§:1053-1061	NULL
.	NULL

7	NULL
.	NULL

Chelleppan	NULL
,	NULL
S.	NULL
,	NULL
V.	NULL
B.	NULL
Kraus	NULL
,	NULL
B.	NULL
Kroger	NULL
,	NULL
K.	NULL
Munger	NULL
,	NULL
P.	NULL
M.	NULL
Howley	NULL
,	NULL
W.	NULL
C.	NULL
Phelps	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1992	NULL
.	NULL

Adenovirus	NULL
ElA	NULL
,	NULL
simian	NULL
virus	NULL
40	NULL
tumor	NULL
antigen	NULL
,	NULL
and	NULL
human	NULL
papillomavirus	NULL
E7	NULL
protein	NULL
share	NULL
the	NULL
capacity	NULL
to	NULL
disrupt	NULL
the	NULL
interaction	NULL
between	NULL
transcription	NULL
factor	NULL
E2F	NULL
and	NULL
the	NULL
retinoblastoma	NULL
gene	NULL
product	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:4549-4553	NULL
.	NULL

8	NULL
.	NULL

Chittenden	NULL
,	NULL
T.	NULL
,	NULL
D.	NULL
M.	NULL
Livingston	NULL
,	NULL
and	NULL
W.	NULL
G.	NULL
Kaelin	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
T/E1A-binding	NULL
domain	NULL
of	NULL
the	NULL
retinoblastoma	NULL
product	NULL
can	NULL
interact	NULL
selectively	NULL
with	NULL
a	NULL
sequence-specific	NULL
DNA-binding	NULL
protein	NULL
.	NULL

Cell	NULL
65:1073-1082	NULL
.	NULL

9	NULL
.	NULL

Dalton	NULL
,	NULL
S.	NULL
1992	NULL
.	NULL

Cell	NULL
cycle	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
cdc2	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:1797-1804	NULL
.	NULL

10	NULL
.	NULL

Devoto	NULL
,	NULL
S.	NULL
H.	NULL
,	NULL
M.	NULL
Mudryj	NULL
,	NULL
J.	NULL
Pines	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
cyclin	NULL
A	NULL
protein	NULL
kinase	NULL
complex	NULL
possesses	NULL
sequence-specific	NULL
DNA	NULL
binding	NULL
activity	NULL
;	NULL
p33cdk2	NULL
is	NULL
a	NULL
component	NULL
of	NULL
the	NULL
E2F-cyclin	NULL
A	NULL
complex	NULL
.	NULL

Cell	NULL
68:167-176	NULL
.	NULL

10a	NULL
.	NULL

Dyson	NULL
,	NULL
N.	NULL
Personal	NULL
communication	NULL
.	NULL

Dyson	NULL
,	NULL
N.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Submitted	NULL
for	NULL
publication	NULL
.	NULL

11	NULL
.	NULL

Giordano	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
McCall	NULL
,	NULL
P.	NULL
Whyte	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Franza	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
cyclin	NULL
A	NULL
and	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
interact	NULL
with	NULL
similar	NULL
but	NULL
distinguishable	NULL
sequences	NULL
in	NULL
the	NULL
adenovirus	NULL
ElA	NULL
gene	NULL
product	NULL
.	NULL

Oncogene	NULL
6:481-485	NULL
.	NULL

12	NULL
.	NULL

Hamel	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
R.	NULL
M.	NULL
Gill	NULL
,	NULL
R.	NULL
A.	NULL
Phillips	NULL
,	NULL
and	NULL
B.	NULL
L.	NULL
Gallie	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
repression	NULL
of	NULL
the	NULL
E2-containing	NULL
promoters	NULL
El-1aE	NULL
,	NULL
c-myc	NULL
,	NULL
and	NULL
RB1	NULL
by	NULL
the	NULL
product	NULL
of	NULL
the	NULL
RB1	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:3431-3438	NULL
.	NULL

13	NULL
.	NULL

Helin	NULL
,	NULL
K.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Lees	NULL
,	NULL
M.	NULL
Vidal	NULL
,	NULL
N.	NULL
Dyson	NULL
,	NULL
E.	NULL
Harlow	NULL
,	NULL
and	NULL
A.	NULL
Fattaey	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
cDNA	NULL
encoding	NULL
a	NULL
pRB-binding	NULL
protein	NULL
with	NULL
properties	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
E2F	NULL
.	NULL

Cell	NULL
70:337-349	NULL
.	NULL

14	NULL
.	NULL

Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
M.	NULL
Blake	NULL
,	NULL
J.	NULL
Azizkhan	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1991	NULL
.	NULL

Role	NULL
of	NULL
E2F	NULL
transcription	NULL
factor	NULL
in	NULL
ElA-mediated	NULL
trans	NULL
activation	NULL
of	NULL
cellular	NULL
genes	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:3547-3552	NULL
.	NULL

15	NULL
.	NULL

Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
S.	NULL
P.	NULL
Chellappan	NULL
,	NULL
J.	NULL
M.	NULL
Horowitz	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
Rb	NULL
with	NULL
E2F	NULL
coincides	NULL
with	NULL
an	NULL
inhibition	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
E2F	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:177-185	NULL
.	NULL

16	NULL
.	NULL

Hiebert	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
M.	NULL
Lipp	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1989	NULL
.	NULL

ElA-dependent	NULL
trans-activation	NULL
of	NULL
the	NULL
human	NULL
MYC	NULL
promoter	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
E2F	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:3594-3598	NULL
.	NULL

17	NULL
.	NULL

Huang	NULL
,	NULL
M.-M.	NULL
,	NULL
and	NULL
P.	NULL
Hearing	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
adenovirus	NULL
early	NULL
region	NULL
4	NULL
open	NULL
reading	NULL
frame	NULL
6/7	NULL
protein	NULL
regulates	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
cellular	NULL
transcription	NULL
factor	NULL
,	NULL
E2F	NULL
,	NULL
through	NULL
a	NULL
direct	NULL
complex	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1699-1710	NULL
.	NULL

Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

Johnson	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1989	NULL
.	NULL

Eukaryotic	NULL
transcriptional	NULL
regulatory	NULL
proteins	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

58:799-839	NULL
.	NULL

Kaelin	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
Jr.	NULL
,	NULL
W.	NULL
Krek	NULL
,	NULL
W.	NULL
R.	NULL
Sellers	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
DeCaprio	NULL
,	NULL
F.	NULL
Ajchenbaum	NULL
,	NULL
C.	NULL
S.	NULL
Fuchs	NULL
,	NULL
T.	NULL
Chittenden	NULL
,	NULL
Y.	NULL
Li	NULL
,	NULL
P.	NULL
J.	NULL
Farnham	NULL
,	NULL
M.	NULL
A.	NULL
Blanar	NULL
,	NULL
D.	NULL
M.	NULL
Livingston	NULL
,	NULL
and	NULL
E.	NULL
K.	NULL
Flemington	NULL
.	NULL

1992	NULL
.	NULL

Expression	NULL
cloning	NULL
of	NULL
a	NULL
cDNA	NULL
encoding	NULL
a	NULL
retinoblastoma	NULL
protein	NULL
with	NULL
E2F-like	NULL
properties	NULL
.	NULL

Cell	NULL
70:351-364	NULL
.	NULL

Kovesdi	NULL
,	NULL
I.	NULL
,	NULL
R.	NULL
Reichel	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1986	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
cellular	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
ElA	NULL
trans-activation	NULL
.	NULL

Cell	NULL
45:219-228	NULL
.	NULL

Kovesdi	NULL
,	NULL
I.	NULL
,	NULL
R.	NULL
Reichel	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1987	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
adenovirus	NULL
E2	NULL
promoter	NULL
binding	NULL
factor	NULL
in	NULL
ElA-mediated	NULL
coordinate	NULL
gene	NULL
control	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:2180-2184	NULL
.	NULL

21a.Lees	NULL
,	NULL
E.	NULL
Personal	NULL
communication	NULL
.	NULL

22	NULL
.	NULL

Lees	NULL
,	NULL
E.	NULL
,	NULL
B.	NULL
Faha	NULL
,	NULL
V.	NULL
Dulic	NULL
,	NULL
S.	NULL
I.	NULL
Reed	NULL
,	NULL
and	NULL
E.	NULL
Harlow	NULL
.	NULL

1992	NULL
.	NULL

Cyclin	NULL
E/edk2	NULL
and	NULL
cyclin	NULL
A/cdk2	NULL
kinases	NULL
associate	NULL
with	NULL
p107	NULL
and	NULL
E2F	NULL
in	NULL
a	NULL
temporally	NULL
distinct	NULL
manner	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1874-1885	NULL
.	NULL

22a.Lees	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Harlow	NULL
,	NULL
and	NULL
N.	NULL
La	NULL
Thangue	NULL
.	NULL

Personal	NULL
communica-	NULL
23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33.	NULL
tion	NULL
.	NULL

Loeken	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
J.	NULL
Brady	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
adenovirus	NULL
EIIA	NULL
enhancer	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

264:6572-6579	NULL
.	NULL

Marshall	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

1991	NULL
.	NULL

Tumor	NULL
suppressor	NULL
genes	NULL
.	NULL

Cell	NULL
64:313-326	NULL
.	NULL

Marton	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
S.	NULL
B.	NULL
Baim	NULL
,	NULL
D.	NULL
A.	NULL
Ornelles	NULL
,	NULL
and	NULL
T.	NULL
Shenk	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
adenovirus	NULL
E4	NULL
17-kilodalton	NULL
protein	NULL
complexes	NULL
with	NULL
the	NULL
cellular	NULL
transcription	NULL
factor	NULL
E2F	NULL
,	NULL
altering	NULL
its	NULL
DNA-binding	NULL
properties	NULL
and	NULL
stimulating	NULL
ElA-independent	NULL
accumulation	NULL
of	NULL
E2	NULL
mRNA	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2345-2359	NULL
.	NULL

Means	NULL
,	NULL
A.	NULL
L.	NULL
,	NULL
J.	NULL
E.	NULL
Slansky	NULL
,	NULL
S.	NULL
L.	NULL
McMahon	NULL
,	NULL
M.	NULL
W.	NULL
Knuth	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farmmham	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
HIP1	NULL
binding	NULL
site	NULL
is	NULL
required	NULL
for	NULL
growth	NULL
regulation	NULL
of	NULL
the	NULL
dihydrofolate	NULL
reductase	NULL
gene	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1054-1063	NULL
.	NULL

Mudryj	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
H.	NULL
Devoto	NULL
,	NULL
S.	NULL
W.	NULL
Hiebert	NULL
,	NULL
T.	NULL
Hunter	NULL
,	NULL
J.	NULL
Pines	NULL
,	NULL
and	NULL
J.	NULL
Nevins	NULL
.	NULL

1991	NULL
.	NULL

Cell	NULL
cycle	NULL
regulation	NULL
of	NULL
the	NULL
E2F	NULL
transcription	NULL
factor	NULL
involves	NULL
an	NULL
interaction	NULL
with	NULL
cyclin	NULL
A	NULL
.	NULL

Cell	NULL
65:1243-1253.	NULL
.	NULL

Mudryj	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
W.	NULL
Hiebert	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
role	NULL
for	NULL
the	NULL
adenovirus	NULL
inducible	NULL
E2F	NULL
transcription	NULL
factor	NULL
in	NULL
a	NULL
proliferation	NULL
dependent	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:2179-2184	NULL
.	NULL

Neill	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1991	NULL
.	NULL

Genetic	NULL
analysis	NULL
of	NULL
the	NULL
adenovirus	NULL
E4	NULL
6/7	NULL
trans	NULL
activator	NULL
:	NULL
interaction	NULL
with	NULL
E2F	NULL
and	NULL
induction	NULL
of	NULL
a	NULL
stable	NULL
DNA-protein	NULL
complex	NULL
are	NULL
critical	NULL
for	NULL
activity	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:5364-5373	NULL
.	NULL

Nevins	NULL
,	NULL
J.	NULL
R.	NULL
1992	NULL
.	NULL

E2F	NULL
:	NULL
a	NULL
link	NULL
between	NULL
the	NULL
Rb	NULL
tumor	NULL
suppressor	NULL
protein	NULL
and	NULL
viral	NULL
oncoproteins	NULL
.	NULL

Science	NULL
258:424-429	NULL
.	NULL

Pagano	NULL
,	NULL
M.	NULL
,	NULL
G.	NULL
Draetta	NULL
,	NULL
and	NULL
P.	NULL
Jansen-Diirr	NULL
.	NULL

1992	NULL
.	NULL

Association	NULL
of	NULL
edk2	NULL
kinase	NULL
with	NULL
the	NULL
transcription	NULL
factor	NULL
EZF	NULL
during	NULL
the	NULL
S	NULL
phase	NULL
.	NULL

Science	NULL
255:1144-1147	NULL
.	NULL

Pagano	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Diirst	NULL
,	NULL
S.	NULL
Joswig	NULL
,	NULL
G.	NULL
Dractta	NULL
,	NULL
and	NULL
P.	NULL
Jansen-Diirr	NULL
.	NULL

1992	NULL
.	NULL

Binding	NULL
of	NULL
the	NULL
human	NULL
E2F	NULL
transcription	NULL
factor	NULL
to	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
but	NULL
not	NULL
to	NULL
cyclin	NULL
A	NULL
is	NULL
abolished	NULL
in	NULL
HPV-16-immortalized	NULL
cells	NULL
.	NULL

Oncogene	NULL
7:1681-1686	NULL
.	NULL

Pearson	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
H.-P.	NULL
Nasheuer	NULL
,	NULL
and	NULL
T.	NULL
S.-F.	NULL
Wang	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
DNA	NULL
polymerase	NULL
alpha	NULL
gene	NULL
:	NULL
sequences	NULL
controlling	NULL
34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

NOVEL	NULL
E2F	NULL
SPECIES	NULL
IN	NULL
HUMAN	NULL
T	NULL
CELLS	NULL
3983	NULL
expression	NULL
in	NULL
cycling	NULL
and	NULL
serum-stimulated	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11:2081-2095	NULL
.	NULL

Qin	NULL
,	NULL
X.-Q	NULL
.	NULL

,	NULL
T.	NULL
Chittenden	NULL
,	NULL
D.	NULL
M.	NULL
Livingston	NULL
,	NULL
and	NULL
W.	NULL
G.	NULL
Kaelin	NULL
,	NULL
Jr.	NULL
1992	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
growth	NULL
suppression	NULL
domain	NULL
within	NULL
the	NULL
retinoblastoma	NULL
gene	NULL
product	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:953-964	NULL
.	NULL

Raychaudhuri	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
Bagchi	NULL
,	NULL
S.	NULL
H.	NULL
Devoto	NULL
,	NULL
V.	NULL
B.	NULL
Kraus	NULL
,	NULL
E.	NULL
Moran	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1991	NULL
.	NULL

Domains	NULL
of	NULL
the	NULL
adenovirus	NULL
ElA	NULL
protein	NULL
required	NULL
for	NULL
oncogenic	NULL
activity	NULL
are	NULL
also	NULL
required	NULL
for	NULL
dissociation	NULL
of	NULL
E2F	NULL
transcription	NULL
factor	NULL
complexes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

Â§5:1200-1211	NULL
.	NULL

Raychaudhuri	NULL
,	NULL
P.	NULL
,	NULL
S.	NULL
Bagchi	NULL
,	NULL
S.	NULL
D.	NULL
Neill	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1990	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
E2F	NULL
transcription	NULL
factor	NULL
in	NULL
adenovirus-in-fected	NULL
cell	NULL
involves	NULL
ElA-dependent	NULL
stimulation	NULL
of	NULL
DNA-binding	NULL
activity	NULL
and	NULL
induction	NULL
of	NULL
cooperative	NULL
binding	NULL
mediated	NULL
by	NULL
an	NULL
E4	NULL
gene	NULL
product	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2702-2710	NULL
.	NULL

36a.Schwarz	NULL
,	NULL
J.	NULL
K.	NULL
,	NULL
S.	NULL
H.	NULL
Devoto	NULL
,	NULL
E.	NULL
J.	NULL
Smith	NULL
,	NULL
S.	NULL
P.	NULL
Chellappan	NULL
,	NULL
L.	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

Jakoi	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1993	NULL
.	NULL

Interactions	NULL
of	NULL
the	NULL
p107	NULL
and	NULL
Rb	NULL
proteins	NULL
with	NULL
E2F	NULL
during	NULL
the	NULL
cell	NULL
proliferation	NULL
response	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:1013-1020	NULL
.	NULL

Shan	NULL
,	NULL
B.	NULL
,	NULL
X.	NULL
Zhu	NULL
,	NULL
P.-L.	NULL
Chen	NULL
,	NULL
T.	NULL
Durfee	NULL
,	NULL
Y.	NULL
Yang	NULL
,	NULL
D.	NULL
Sharp	NULL
,	NULL
and	NULL
W.-H.	NULL
Lee	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
cellular	NULL
genes	NULL
encoding	NULL
retionblastoma-associated	NULL
proteins	NULL
:	NULL
identification	NULL
of	NULL
a	NULL
gene	NULL
with	NULL
properties	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
E2F	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:5620-5631	NULL
.	NULL

Shirodkar	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Ewen	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
DeCaprio	NULL
,	NULL
J.	NULL
Morgan	NULL
,	NULL
D.	NULL
M.	NULL
Livingston	NULL
,	NULL
and	NULL
T.	NULL
Chittenden	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
transcription	NULL
factor	NULL
E2F	NULL
interacts	NULL
with	NULL
the	NULL
retinoblastoma	NULL
product	NULL
and	NULL
a	NULL
p107-cyclin	NULL
A	NULL
complex	NULL
in	NULL
a	NULL
cell	NULL
cycle-regulated	NULL
manner	NULL
.	NULL

Cell	NULL
68:157-166	NULL
.	NULL

Thalmeier	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Synovzik	NULL
,	NULL
R.	NULL
Mertz	NULL
,	NULL
E.-L.	NULL
Winnacker	NULL
,	NULL
and	NULL
M.	NULL
Lipp	NULL
.	NULL

1989	NULL
.	NULL

Nuclear	NULL
factor	NULL
E2F	NULL
mediates	NULL
basic	NULL
transcription	NULL
and	NULL
trans-activation	NULL
by	NULL
ElA	NULL
of	NULL
the	NULL
human	NULL
MYC	NULL
promoter	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:527-536.	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
I.-C.	NULL
Ho	NULL
,	NULL
P.	NULL
R.	NULL
Bohjanen	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
S.	NULL
Miesfeldt	NULL
,	NULL
L.	NULL
Zhang	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
B.	NULL
Karpinski	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992.	NULL
cis-acting	NULL
sequences	NULL
required	NULL
for	NULL
inducible	NULL
interleukin-2	NULL
enhancer	NULL
function	NULL
bind	NULL
a	NULL
novel	NULL
ets-related	NULL
protein	NULL
,	NULL
Elf-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1043-1053	NULL
.	NULL

Weintraub	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
C.	NULL
A.	NULL
Prater	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Dean	NULL
.	NULL

1992	NULL
.	NULL

Retinoblastoma	NULL
protein	NULL
switches	NULL
the	NULL
E2F	NULL
site	NULL
from	NULL
positive	NULL
to	NULL
negative	NULL
element	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
358:259-261	NULL
.	NULL

Whyte	NULL
,	NULL
P.	NULL
,	NULL
N.	NULL
M.	NULL
Williamson	NULL
,	NULL
and	NULL
E.	NULL
Harlow	NULL
.	NULL

1989	NULL
.	NULL

Cellular	NULL
targets	NULL
for	NULL
transformation	NULL
by	NULL
the	NULL
adenovirus	NULL
E1A	NULL
proteins	NULL
.	NULL

Cell	NULL
56:67-75	NULL
.	NULL

Yee	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
P.	NULL
Raychaudhuri	NULL
,	NULL
L.	NULL
Jakoi	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
adenovirus-inducible	NULL
factor	NULL
E2F	NULL
stimulates	NULL
transcription	NULL
after	NULL
specific	NULL
DNA	NULL
binding	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9:578-585.	NULL
.	NULL

Yee	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
R.	NULL
Reichel	NULL
,	NULL
I.	NULL
Kovesdi	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1987	NULL
.	NULL

Promoter	NULL
interaction	NULL
of	NULL
the	NULL
ElA-inducible	NULL
factor	NULL
E2F	NULL
and	NULL
its	NULL
potential	NULL
role	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
a	NULL
multi-component	NULL
complex	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

6:2061-2068	NULL
.	NULL

Zamanian	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
N.	NULL
B	NULL
.	NULL

La	NULL
Thangue	NULL
.	NULL

1992	NULL
.	NULL

Adenovirus	NULL
ElA	NULL
prevents	NULL
the	NULL
retinoblastoma	NULL
gene	NULL
product	NULL
from	NULL
repressing	NULL
the	NULL
activity	NULL
of	NULL
a	NULL
cellular	NULL
transcription	NULL
factor	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

11:2603-2610	NULL
.	NULL

